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ABSTRACT 
 
Eduardo E. Valverde: THE ASSOCIATION OF INTERNALIZED HIV STIGMA WITH 
RETENTION IN HIV CARE 
 (Under the direction of Bryce B. Reeve) 
 
Internalized HIV stigma should be an important construct in terms of explaining poor 
retention in HIV care given that it already plays a detrimental role in several components of the 
HIV medical care process such as negatively impacting access to HIV care and HIV medication 
adherence, and contributing to comorbid conditions that may complicate the HIV disease 
process. Yet, there is paucity on the research that explores the association of internalized HIV 
stigma with retention in HIV care.  
 
We conducted secondary data analysis of interview and medical record abstraction data 
collected from a total of 188 HIV positive men and women receiving care at the University of 
Miami/Jackson Memorial Hospital (UM/JHM) Special Immunology (SI) Clinics, located in 
Miami, Florida. Demographic characteristics, HIV risk behaviors, HIV care related factors, as 
well as psychosocial constructs were analyzed to explore the association of internalized HIV 
stigma with two retention in HIV care measures: 1- number of missed clinical visits (via a 
Poisson regression analysis), and 2- the proportion of appointment adherence (via a multiple 
regression analysis.  
 
Results from the analysis indicate that gender and age were significantly associated with 
both retention in HIV care measures. Additionally, the Poisson regression analysis indicated that 
the level of engagement with an HIV care provider moderated the relationship between 
internalized HIV stigma and missed visits such that in participants with low and medium 
internalized HIV stigma, better engagement with provider had a significant effect in reducing the 
missed visits rate. However, for individuals experiencing high internalized HIV stigma, 
engagement with provider did not have a significant effect in reducing missed visits. 
 
Our plan for change to improve HIV retention in care rates at the UM/JHM clinics is 
modelled after John Kotter’s 8 Steps Leading to Organizational Change. The plan involves 
lobbying the leadership of the UM/JHM clinics to implement interventions that improve 
engagement with providers for patients with low and medium internalized HIV stigma, as well as 
implementing interventions that reduce internalized HIV stigma, followed by intervention to 
improve engagement with providers directed to patient with high internalized HIV stigma.
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CHAPTER 1: INTRODUCTION 
 
Statement of the Issue 
Internalized Human Immunodeficiency Virus (HIV) stigma, defined as the shame 
associated with HIV/AIDS and the fear of being discriminated against, which are both felt by 
persons living with HIV, should be an important construct in terms of explaining poor retention 
in HIV care given that it already plays  a detrimental role in several components of the HIV 
medical care process such as negatively impacting access to HIV care and HIV medication 
adherence, 1,2,3 and contributing to  comorbid conditions that may complicate the HIV disease 
process. 3, 4 Given the detrimental impact of internalized HIV stigma on several aspects of HIV 
care, it is plausible to hypothesize, as Bruce Link hypothesized with mental illness 5 that it also 
plays an important role in shaping social interactions with medical providers that may impact 
retention in HIV medical care. Determining what role internalized HIV stigma plays in retention 
in HIV care may have important clinical and policy making (including resource allocation) 
implications. This can make a difference in how we train providers (i.e. trainings to minimize 
stigma or better engage with patients) or implement patient level interventions to reduce 
internalized HIV stigma in order to improve retention in care.  The dissertation analysis will 
focus on measures of retention in care that may impact HIV clinical care and 
policy/administrative/resource allocation decision making in order to assist HIV care providers 
and public health professionals achieve the goals and objectives of the National HIV/AIDS 
Strategy of the United States.
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Background 
 In 2008 the White House Office of National AIDS Policy (ONAP) was tasked with 
leading the effort to develop a national HIV/AIDS strategy that would address a domestic HIV 
epidemic that had remained stable at around 50,000 new diagnosed cases per year since the 
beginning of the new millennia. The resulting document, the National HIV/AIDS Strategy for 
the United States 2010 6 delineates three primary goals: 1) reducing the number of people who 
become infected with HIV, 2) increasing access to care and optimizing health outcomes for 
people living with HIV, and 3) reducing HIV-related health disparities. Each of these goals has 
specific objectives attached to them, and each of these objectives in turn have specific strategies 
that, according to ONAP, will allow government agencies and their community partners to 
achieve all the goals and objectives of the NHAS within a 5 year period of time. Under goal 
number 2- increasing access to care and optimizing health outcomes for people living with HIV- 
one of the objectives specifically mentions the need to “maintain people living with HIV in 
care." This focus of the NHAS on maintaining people in care (or retaining them in care) 
addresses a critical step necessary to ensure that all HIV infected patients are receiving the best 
medical care available.  
 
The Health Resources and Services Administration (HRSA), which is the federal agency 
that oversees the Ryan White HIV/AIDS Program (the insurance program of last resort used by 
HIV infected individuals who do not have healthcare insurance or financial resources to pay for 
the cost of treatment services), developed the Engagement in Care Continuum (Figure 1) that 
allow us to visualize the different stages by which patients engage in HIV care.  The HRSA 
Engagement in Care Continuum recognizes full engagement in HIV care as the last step 
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necessary in order for the patient to reap the full benefits of the clinical resources available in 
order to maximize health outcomes, but also identifies 2 stages (Entered HIV care but lost to 
follow-up & Cyclical or intermittent user of HIV care) in which patients are not fully retained in 
care.7 
Figure 1. HRSA Engagement in Care Continuum 
 
Source: HRSA. Outreach: engaging people in HIV care: summary of a HRSA/HAB 2005 
consultation on linking PLWH into care. 2006 
  
The NHAS focus on engagement in care reflected an ongoing concern among clinical 
practitioners from across the country that saw that a significant number of patients were 
accessing care but later were lost to follow-up or failed to adhere to clinical care appointments. 8, 
9   These concerns were validated in 2011 when the Centers for Disease Control and Prevention 
(CDC)  in a Mortality and Morbidity Weekly Report 10 published that  of 725,302 individuals 
diagnosed with HIV as of 2008 who had accessed HIV care at some point after their diagnosis, 
34% had not been retained in HIV care (Figure 2). These figures have been updated recently, and 
according to the newest estimates almost 50% of individuals diagnosed and living with HIV are 
not retained in care. 11 Having such a large proportion of HIV-infected individuals not retained in 
medical care can potentially be a serious public health problem. These individuals do not have 
access to HIV medications and other medical services which can prevent diseases associated 
with HIV infection. Those who access care again at a later stage in their disease have a higher 
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probability of negative clinical outcomes including death. 12, 13 Furthermore, those who begin 
using HIV medications and stop due to dropping out of care can develop viral resistance, 14 
which has been associated with higher mortality. 15  
 
In addition, little is known of the sex and drug use risk behaviors of individuals who drop 
out of care. Some earlier studies suggested that individuals that exhibit poor retention in care 
behaviors also engaged in increased HIV transmission risk behaviors. 16, 17 (Current models 
developed by CDC focused on estimating the rate and number of HIV transmissions from HIV-
infected persons in the United States along each step of the HIV care continuum (diagnosis, 
retention in medical care, antiretroviral therapy, and viral suppression) show that HIV-infected 
undiagnosed persons and persons diagnosed with HIV but not retained in care were responsible 
for over 90% of HIV transmissions in 2009. 18 This information is important because population 
studies have shown an association between HIV treatment, lower community viral load, and 
lower population HIV infection rates. 19 In other words, improving access and retention in HIV 
care can have both clinical and prevention level benefits.   
 
Figure 2. Number and percentage of HIV-infected persons engaged in selected stages of the 
continuum of HIV care — United States  
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Barriers to Retention in HIV Care  
 The Institute of Medicine (IOM) in the landmark report Access to Healthcare in America 
classified reasons for not accessing medical care into financial, structural, and personal (Figure 
3). 20 Financial barriers according to the IOM were those that may hinder health care access via 
the person's eligibility/insurability, benefit coverage, and reimbursement levels of providers. 
Structural barriers could be envisioned as "...impediments to medical care directly related to the 
number, type, concentration, location, or organizational configuration of health care providers". 
The IOM also noted that personal barriers could be understood as demographic characteristics 
shared by the population such as education and income levels, or cultural traits such as attitudes 
towards disease. The IOM model allows us to classify the types of barriers that may impact 
adequate use of medical services for all types of diseases.   
 
Figure 3. IOM Model of Access to Personal Health Care Services. 
 
 
Using the IOM's classification as a framework, the literature indicates that barriers to 
retention in HIV care among HIV infected patients  include financial level barriers such as lack 
of health insurance or having public health insurance; 15, 21 structural level barriers such as lack 
of transportation, fragmented HIV care services, and problems accessing clinical care; 22,23,24,25  
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and  personal level barriers such as female gender, younger age, being a racial/ethnic minority, 
lack of social support, multiple caregiving responsibilities, having mental health and/or 
substance abuse problems, being homeless, having a lower CD4 count, not having an AIDS 
diagnosis, having poor communication with providers, and negative perceptions of the health 
care system. 26-37,  
 
Internalized Stigma and Retention in HIV Care - Theoretical Considerations 
 Among personal level factors involved as a barrier to retention in HIV care, one that has 
not been fully explored is the role of internalized HIV stigma. Ervin Goffman defined stigma as 
a deeply discrediting attribute that reduces the bearer “from a whole and usual person to a 
tainted, discounted one with a spoiled identity.” 38 He advanced the idea that individuals in 
society stigmatize on the basis of what they consider is a behavior outside of the norm (or a 
deviant behavior). According to Goffman, it is through the process of labeling, and assigning 
meaning to the labels, that a society makes stigmatization a reality. The social label of deviant 
makes others in society and the stigmatized individuals themselves view the stigmatized as 
“discredited or undesirable.”  
 
 Link and Phelan took a similar approach as Goffman but extended their 
conceptualization of stigma beyond labeling. According to Link and Phelan, stigma occurs via 
five processes: 1- people distinguish and label human differences; 2- the dominant cultural 
beliefs link labeled persons to negative stereotypes; 3- labeled persons are placed in distinct 
categories so they can be separated; 4- labeled persons experience status loss and discrimination 
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that lead to unequal outcomes (including health outcomes), and finally; 5- the dominant group’s 
power allows the stigmatization to become established in society. 39 
 
Link also advanced the idea that unequal outcomes (including health outcomes) among 
the stigmatized may occur without actual discrimination. In a “modified labeling theory” looking 
at the effects of stigma on people with mental illnesses 40 and developed based on the work of 
Scheff,41 Link postulated the idea that individuals will develop conceptions about a particular 
stigmatized behavior as part of the socialization process that is constantly occurring within a 
culture. Once these conceptions of what it means to have a particular stigma become established 
as a lay theory, people will form expectations as to whether individuals possessing the stigma 
will be rejected by others. These expectations become particularly important for those who have 
or acquire the stigma because the possibility of devaluation and discrimination becomes 
personally relevant. As Link describes it “If one believes that others will devalue and reject 
people because they possess a particular stigma, one must now fear that this rejection applies 
personally.” If this believe becomes part of the individual’s world view, in other words, if the 
stigma is internalized, that perception can have serious negative consequences. Link postulated 
that, in the case of mental illness, patients who had been hospitalized for mental illnesses acted 
less confidently and more defensively, or simply avoided potentially threatening contact 
altogether (thus potentially avoiding mental health care) because they were expecting and fearing 
rejection from others in their social network including health care providers. This is turn made 
individuals more vulnerable to negative health outcomes or health behaviors. A description of 
Link’s Modified Labeling Theory is presented in Figure 4.  
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Figure 4.  Bruce Link’s Labeling Theory 
 
This dissertation posits that internalized HIV stigma may operate in a similar manner. 
Almost 30 years into the HIV epidemic individuals in our society have developed a particular 
conception of what it means to be HIV positive. This conception is based in large part on the 
association of HIV infection with behaviors such as homosexuality, intravenous drug use, and 
promiscuity, all behaviors that are already stigmatized in our society. In other words, a diagnosis 
of an HIV infection is already loaded with a number of stigmatized conceptions that together 
help create this “supra-conception” that defines all HIV-infected.  This conception has become 
part of the socialization process that is constantly occurring within our culture shaping human 
interactions.  
 
In addition, besides HIV affecting groups that are already stigmatized in our society, HIV 
infection is also perceived as a death sentence by lay persons, which adds a layer of irrational 
fear, shaping even more negatively how the HIV infected are perceived. This conception of what 
it is to be an HIV positive individual has become established as a lay theory and for many 
affected by the disease the possibility of devaluation and discrimination has become personally 
relevant. Entering HIV care has become for many a step into fully accepting this stigmatized 
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condition, and once the complete awareness of the new condition is internalized, individuals may 
respond by withdrawing from care if they expect and fear rejection from others, particularly from 
those that are supposed to care for them. For the HIV infected, particularly for those in care, HIV 
care providers are an essential component of their social network. HIV care providers make the 
difference between a healthy life or infirmity, or even death for those affected by HIV. 
Perceptions of stigmatization by health care providers and how this stigmatization has negatively 
impacted accessing HIV care and medication adherence, has already been reported by HIV 
positive individuals, 1, so has the effect of poor patient-provider interaction on retention in care, 
43, 44 therefore it is plausible to hypothesize that patient-provider interaction may moderate the 
relationship between internalized HIV stigma and retention in care. An adaptation of Link’s 
modified labeling theory applied to the association of internalized HIV stigma with retention in 
HIV care and the potential moderating effect of provider interaction is described in Figure 5. 
 
Figure 5. Labeling Theory Modeling the Association of Internalized HIV Stigma  
with Retention in HIV Care  
 
Step1                              Step 2                            Step 3                          Step 4                    Step5 
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Modeling the Association of Internalized HIV Stigma with Retention in HIV Care 
 
In our conceptual theoretical model, we see how societal perception of what it means to 
be HIV infected become internalized by individuals in our society who perceive those infected 
by HIV as devalued human beings who may be discriminated against because of their HIV 
infection. Societal conceptions of what it means to be HIV-positive (the label of HIV-infected) 
become relevant to the individual once he/she enrolls in HIV care. Once enrolled in care, the 
expectation and fear of rejection, may lead the individual to withdraw himself/herself or avoid 
potentially threatening social interactions (interactions where the stigmatized condition is or may 
be revealed). The patient –provider interaction, a critical social interaction for the HIV positive 
individual in care, may be affected by the degree in which the HIV stigma is internalized leading 
to impacting HIV care behaviors or outcomes, in this case, retention in HIV care. Internalized 
HIV stigma may operate in a direct way so that it impacts on retention in care without the need 
of being shaped by the patient-provider interaction, or the patient-provider interaction may 
moderate the relationship between internalized HIV stigma and poor retention in care. Testing 
this conceptual model should help us understand if (and how) internalized HIV stigma impacts 
retention in HIV care. 
 
Measuring Retention in HIV Care  
One of the challenges in studying retention in HIV care relates to measurement. 
Researchers have used many different criteria for measuring retention in care, which has created 
some confusion on what exactly is being measured and for what purpose.  Recently, Mugavero 
and colleagues in an effort to standardize the measurement of retention in HIV care synthesized 
11 
 
all the published literature on retention in HIV care and described five different methods in 
which retention in HIV care could be measured depending on the objective of the analysis.45   
 
According to Mugavero the simplest and most widely used way of measuring retention in 
care is by counting Missed Visits, regardless of how many visits have been scheduled. Another 
way of measuring retention in care is by measuring appointment adherence during an 
observation period of interest as a proportion that captures the number of completed visits in the 
numerator and the number of total scheduled visits in the denominator. A third way of measuring 
retention in care is by calculating the Visit constancy, which evaluates the proportion of time 
intervals (typically 3-6 months when looking at HIV care) with at least 1 completed clinic visit 
during an observation period of interest. Gaps in care, the 4th way of measuring retention in care, 
calculates the time interval between completed clinic visits in a typical time interval ranging 
from 3 and 12 months. The final measure is the one used by HRSA called the HRSA HIV/AIDS 
Bureau (HAB) Medical Visits Performance Measure. The HRSA HAB measure captures 
whether a patient had 2 or more completed clinic visits separated by 3 or more months in time 
during a 12-month observation period.45 
 
Retention in Care for Improving Clinical Care and Policy Decision Making 
Mugavero and colleagues examined how retention in care measures could be utilized to 
improve the HIV care and treatment system. Two areas that were examined in which these 
measures could have an impact included improving the clinical care of HIV patients, and as a 
tool for clinic administrators and policy makers to improve administrative & policy decision 
making activities.45 
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Retention in Care Measures and Clinical Care 
The relationship between retention in HIV care and several HIV biomarkers as well as 
HIV clinical outcomes has been well described in the literature. From failure to suppress viral 
load, developing clinically significant drug resistance, poor adherence to antiretroviral therapy, 
predicting the presence of an AIDS-defining CD4 cell count (independent of Highly Active 
Antiretroviral Therapy use), and  higher mortality rates, retention in care seems to be a critical 
aspect to consider when trying to improve the clinical care of patients. 46, 47, 48, 49, 50  
 
Mugavero noted that for clinicians, the missed visits measure could be the most useful to 
incorporate in their routine patient care activities. This measure could be a way to identify at the 
clinic level patients that need additional help to keep their appointments, or patients that need 
additional help because of potentially unmet needs. Mugavero’s own analysis of how this 
measure has been used found it associated with patient outcomes including higher mortality. 45  
 
Retention in Care Measures and Administrative/Policy Decision Making 
Another important area in which these measures can be used is as administrative/policy 
tools. The appointment adherence measure for example can be used to track retention in care 
longitudinally as well as to compare appointment adherence between units within clinics.  Clinic 
administrators from individual hospitals/clinics can use this information in order to improve 
optimal clinic scheduling including optimal staffing and health care resource needs.  For policy 
planning and/or evaluation, program administrators of agencies like HRSA, which as previously 
mentioned funds the Ryan White program, can look at retention in care rates across clinics 
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nationwide and use this information to plan regional and national resource allocation needs in 
collaboration with State or County health agencies.  
 
Some of these activities may include policy advocacy in certain States or Counties where 
retention in care rates are poor and changes in legislation are required to shift funds to retention 
in care practices. Likewise, policy actions at the national level may require that federal insurance 
programs such as Medicaid and Medicare (which combined fund 40% of all HIV care in the U.S) 
require public and private healthcare providers who receive funds from these program to 
demonstrate improvement in HIV retention in care rates as a way to demonstrate improvements 
in care coordination, and population and public health.  
 
These requirements are more likely now that a key provision of the American Recovery 
and Reinvestment Act of 2009, the adoption and demonstrated “meaningful use” of electronic 
medical records (EMR), has gone into effect as of January 2014. Improving care coordination as 
well as population and public health are examples of “meaningful use” of EMRs, as defined by 
HealthIT.gov, which also includes  improving quality, safety,  and efficiency of care; reducing 
health disparities; and engaging patients and family in the care process. Retaining HIV-infected 
patients has the potential to also help in a long term goal of health policy planners: to help 
contain health care costs. Several researchers have noted that this can be achieved by improving 
HIV-specific health outcomes and reducing emergency department visits and 
hospitalizations.51,52  
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Research Purpose and Specific Aims  
This dissertation will be used to address this question: To what extent does internalized 
HIV stigma relate with retention in care among HIV positive individuals accessing HIV care? 
The dissertation aims are to: 
(1) Assess the extent to which internalized HIV stigma is associated with retention in HIV care. 
(2)  Assess whether engagement with provider moderates the relationship between HIV stigma 
and retention in HIV care. 
15 
 
CHAPTER 2: REVIEW OF THE LITERATURE 
 
Context of Search 
The field of retention in HIV care is relatively new and so is exploring the barriers and 
facilitators that impact retention in HIV care. This growing field has become more prominent 
given the focus of the federal government through the National HIV/AIDS Strategy (NHAS) in 
increasing the number of HIV infected retained in HIV medical care, and the increasing federal 
funds that are being allocated for this objective. The number of studies describing barriers and 
facilitators to retention in HIV care has increased significantly over the last 10 years.   
 
The field of internalized HIV stigma is also relatively new. Although efforts to minimize 
stigma related to HIV have been on the forefront of HIV prevention strategies around the world 
since the beginning of the epidemic, most work on stigma has been focused on enacted stigma 
(or the act of stigmatizing) and how to reduce the stigmatization that HIV infected individuals 
face every day by members of their society. The research on the impact of internalized HIV 
stigma on health outcomes and risk behaviors is a recent phenomenon of the last 10 years.   This 
systematic review of the literature on the relationship of stigma and its impact on retention in 
HIV care is intended to shed light on the literature that explores a phenomenon that is more than 
likely occurring in almost every HIV clinical setting but that has not been systematically 
evaluated. Because both of these fields are relatively new it is important to have clear definitions 
of the concepts.
16 
 
Definitions 
Human Immunodeficiency Syndrome (HIV) - Human immunodeficiency virus; a 
retrovirus that causes AIDS by infecting CD4 cells of the immune system. The most common 
serotype, HIV-1, is distributed worldwide, while HIV-2 is primarily confined to West Africa. 
Also called AIDS virus, human T-cell leukemia virus type III, human T-cell lymphotrophic virus 
type III, lymphadenopathy-associated virus. HIV uses CD4 cells to replicate, later destroying 
them, thus debilitating the human immune system.  
Acquired Immunodeficiency Syndrome - a syndrome involving a defect in cell-mediated 
immunity that has a long incubation period, follows a protracted and debilitating course, is 
manifested by various opportunistic diseases or AIDS defining conditions. Without treatment has 
a poor prognosis. 
HIV Infected - having a positive reaction on a test for the human immunodeficiency 
virus; used to indicate that an individual has been infected with the human immunodeficiency 
virus. 
CD4+ lymphocyte cell test - Tests for CD4 cells monitor disease progression in HIV 
infection. The CD4 lymphocyte count is used to track the progression of HIV infection and 
disease. 
Viral Load - the amount of HIV in a sample of blood. 
Viral Load count - A blood test that measures the quantity of active virus in the blood. 
Results are expressed as the number of copies per milliliter of blood plasma. Viral load testing is 
used to determine when to initiate and/or change HIV medication regimens.  
17 
 
HIV Antiretroviral medication - Drugs that inhibit the reproduction of HIV, human 
immunodeficiency virus, the causative agent of AIDS. The goal of the medication is to move the 
viral load down, ideally to undetectable levels.  
Undetectable Viral Load - Viral load count that it is below what a laboratory test can 
find. In general, the viral load will be declared "undetectable" if it is under 40 to 75 copies in a 
sample of blood. The exact number depends on the laboratory that analyzes the test. The patient 
still has HIV and needs to stay on ART to remain healthy. 
Retention in HIV medical care - Continuous engagement in appropriate medical care. 
Multiple ways have been used to measure retention in HIV care. The five methods most widely 
used have been: Missed Visits, appointment adherence, Visit Constancy, Gaps in Care, and the 
HRSA HIV/AIDS Bureau medical visits performance measure. 
Barriers to HIV care - Financial, structural, and personal reasons for not accessing HIV 
care. 
Stigma - The holding of derogatory social attitudes or cognitive beliefs, a powerful and 
discrediting social label that radically changes the way individuals view themselves or the way 
they are viewed by others. 
Internalized HIV Stigma - The shame associated with HIV/AIDS and the fear of being 
discriminated against, which are both felt by persons living with HIV. Internalized stigma causes 
refusal or reluctance to disclose one’s HIV status, or denial of one’s HIV/AIDS.  
Enacted Stigma – Involves the process of dehumanizing and sometimes the 
depersonalization of others into stereotypic caricatures.  
Layered Stigma - Also known as intersecting stigma, or compound stigma, refers to the 
multiple stigmas that individuals may face, particularly marginalized individuals. 
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Discrimination - Refers to any form of arbitrary distinction, exclusion, or restriction 
affecting a person, usually but not only by virtue of an inherent personal characteristic or 
perceived belonging to a particular group—in the case of HIV and AIDS, a person’s confirmed 
or suspected HIV-positive status. 
Social support - The perception and actuality that one is cared for, has assistance 
available from other people, and that one is part of a supportive social network. 
Social Network - Interactive field of persons made up of a set of actors (such as 
individuals or organizations) and a complex set of the dyadic ties between these actors. 
Self-efficacy - Refers to an individual's belief in his or her capacity to execute behaviors 
necessary to produce specific performance attainments. Self-efficacy reflects confidence in the 
ability to exert control over one's own motivation, behavior, and social environment. 
 
Selection of the Literature 
The literature was searched for empirical studies correlating sigma with retention in HIV 
care. Even though the field of "retention in HIV care" is relatively new, meaning that most of the 
publications will probably have been published in the last 10 years, individuals have been 
diagnosed and have accessed HIV care for the past 30 years. Taking this into consideration I 
decided to include all empirical studies that have been published since 1985 when the first HIV 
screening test was available in the United States.  It was also decided that because the term 
"retention in HIV care" has just been recently used by researchers and policy makers, we were 
going to examine studies and reports that assessed access to HIV care to broaden the initial 
search but later focus on studies that examined instances of assessing retention in HIV care. In 
terms of internalized stigma, it was decided that because researchers are using several variations 
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of this term to measure the same construct (internalized stigma, felt stigma or just stigma) the all-
encompassing term “stigma” was going to be used to broaden the search. Findings related to 
stigma and retention in HIV care referenced in book chapters, dissertations, and non-peer-
reviewed journals were also omitted. Finally, for expediency, the decision was made to focus the 
search on articles published in peer-reviewed, English-language journal s even though relevant 
studies could have been published in other languages. 
 
A systematic search was performed using PubMed which accesses MEDLINE, and 
Sociological Abstracts using the same search terms for both search engines).  Bibliographies of 
relevant articles, and related citations in PubMed and Sociological Abstracts were also searched 
as part of a technique called “snowballing” to identify additional applicable studies. Searches 
were limited to publication dates of 01/01/1985 – 1/15/2015. 
Table 1. Literature Search Strategy 
ALL Searches were limited to English, Publication date of 01/01/1985 – 1/15/2015 and 
INCLUDE: 
Concept Key words, search terms 
Stigma "social stigma"[MeSH Terms] OR ("social"[All Fields] AND "stigma"[All 
Fields]) OR "social stigma"[All Fields] OR "stigma"[All Fields])  
AND 
Access “access[All Fields] 
Retention "retention (psychology)"[MeSH Terms] OR ("retention"[All Fields] AND 
"(psychology)"[All Fields]) OR "retention (psychology)"[All Fields] OR 
"retention"[All Fields]) 
                                                             AND 
HIV Care Hiv"[MeSH Terms] OR "hiv"[All Fields]) AND care[All Fields] 
 
Inclusion/exclusion criteria  
Selection criteria 
Besides the language and publications dates the inclusion criteria previously mentioned, 
two other inclusion criteria were used for this review.  First, the study had to focus on 
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internalized stigma in relation to retention in HIV care, not care for other type of disease or 
conditions (ex. substance abuse treatment). Second, the study had to focus on internalized stigma 
as a barrier or facilitator of retaining HIV individuals in clinical care. Articles or reports were 
excluded if they assessed the correlation of internalized stigma with accessing HIV care for the 
first time. 
 
All abstracts identified through the electronic searches were screened for the inclusion 
and exclusion criteria. The background, methods, and results sections of all abstracts or reports 
were examined for any mention of internalized stigma in relation to retention in HIV care. If the 
abstract and report mentioned internalized stigma (or felt stigma) in relation to retention in HIV 
care, the full text of the article was examined.  Additional criteria for article selection included: 
1. Study Design - Observational studies, randomized control trials conducted worldwide, 
written in English and published since 1/1/1985 were included. 
2. Types of participants - HIV diagnosed individuals who have accessed HIV medical care. 
3. Internalized Stigma and Retention in Care Measures - Studies were analyzed and the 
Internalized Stigma and Retention in Care measures were described.  
 
Process for reviewing articles  
Abstracts or reports that referenced internalized stigma in terms of retention in HIV care 
were examined to determine if the relationship existed or not and/or if it was mediated or 
moderated by another construct. All relevant articles and reports were recorded on a summary 
sheet that included authors, year it was published, characteristics of the target population 
(gender, race, sexual orientation, etc.), and major findings of the article or report. 
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Literature Review Results  
Initial search using the terms “stigma,” “access,” and “HIV Care” yielded at total of 369 
articles in PubMed and 87 articles in Sociological Abstracts. From the 456 articles, 441 were 
excluded after review of the title for any mention of one of the exclusion criteria and/or cursory 
examination of the background, methods and results sections of the abstracts (355 in PubMed, 86 
in Sociological Abstracts). A second search using the terms “stigma,” “retention,” and “HIV 
care” yielded a total of 56 articles in PubMed and 5 articles in Sociological Abstracts. From the 
61 articles, 47 were excluded after review of the title for any mention of one of the exclusion 
criteria and/or cursive examination of the background, methods and results sections of the 
abstracts (44 in PubMed, 3 in Sociological Abstracts). The total initial search included 517 
studies of which 488 were excluded for not meeting the eligibility criteria after a cursory 
examination of the background, methods and results sections of the abstracts. Out of the 
remaining 29 articles, 3 articles were duplicated in PubMed and Sociological Abstracts. After 
full review of the remaining 26 manuscripts 13 were removed for not meeting the eligibility 
criteria, leaving a total of 13 articles.  Examinations of the references (snowballing) of the final 
13 studies yielded an additional 3 studies that met the eligibility criteria bringing the final total of 
studies included in the review to 17. A visual description of this process is reflected in Figure 6.  
 
Full examination of the final 17 studies/reports indicated that the majority of studies and 
reports were published in the United States (11 out 17). Among the studies, 2 were longitudinal 
studies, 5 were cross sectional studies, two utilized mixed methods, and 8 were qualitative 
studies. Fifteen of the seventeen studies (88%) had been published in the last 5 years with the 
oldest one published eight years ago in 2007. All were published in peer reviewed journals.  
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Seven studies measured retention in care via medical record. 54, 55, 56, 57, 58, 59 Four studies 
measured retention in care using a visit constancy measure - three of the four focused on at least 
1 completed visit within a 6 month interval period over a 1 year period of time, 56, 57, 59 while the 
fourth one measured retention in care as 2 or more visits within a 1 year period of time 
(irrespective of interval).55 
Figure 6.  Flowchart of literature search of empirical studies correlating internalized 
stigma with retention in HIV care. 
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Wolf and colleagues defined not retained in care as patients who had no contact with the 
clinic for four months or more during the year before the initiation of project activities,54 Dietz et 
al measured retention in care via appointment adherence (proportion of appointments kept of all 
appointments scheduled).58 Finally Earnshaw and colleagues measured retention in care using 
the definition in place at the clinic from which participants were recruited, which  recommended 
that HIV patients  have a care visit at least once every 3 months. Participants were considered to 
have had a gap in care if they had not had an HIV medical visit in a 3 month period.56 Five 
studies used validated stigma scales. 44, 54, 56, 57,  
 
All the studies except two reported a relationship between internalized stigma and 
retention in HIV care. Naar-King and colleagues did not find a  significant association between 
internalized stigma and retention in care, but they did note that patients who reported high levels 
of stigma at baseline and continued to do so at follow-up had less than adequate retention in 
care.59 
 
Several authors found that in conjunction with stigma, HIV care related factors such as 
patient-provider interactions, 41, 44, 53, 60, 61, 62, 63  problems with the clinic, such as appointment 
scheduling, 22, 41, 62, 63, 64, 65,  and problems taking the HIV medications, 22, 60, 64, 65 where 
negatively correlated with retention in HIV care. 
 
Others researchers reported patient level factors associated with retention in care such as 
poverty, 41, 64marihuana use, 58 lack of social support, 60, 61, 65 high risk behaviors such as alcohol 
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and drug use, 60, 61, 63 65  mental health issues such as depression, 61, 65 and the stigma associated 
with being a man who has sex with other men. 57 
 
Table 2. Characteristics of studies assessing the relationship of internalized HIV stigma 
and retention in HIV care 
Author 
and Year 
Country Study 
Design 
Methods 
Sample Major Findings Internalized 
Stigma And 
Retention In 
Care Measures 
Wolf et 
al., 2014 
 
Kenya 
 
Qualitative 
 
27 HIV 
positive 
youths 
 
HIV-related stigma was 
the overarching factor to 
poor retention in care 
among HIV + youth. 
Stigma operated on 
multiple levels to 
influence retention, 
including in the 
home/family, at school, 
and at the clinic. In all 
three settings, 
participants’ fear of 
stigma due to disclosure 
of their HIV status 
contributed to poor 
retention. 
Internalized 
Stigma measure: 
Self report 
Retention in 
HIV care 
measure: 
Medical record 
review 
Valenzue
la et al., 
2014 
Peru Cross 
Sectional 
176 HIV 
infected 
individuals 
(66 out of 
care, 110 in 
care) 
Stigma scores were 
higher for the out of-care 
compared to the in-care 
patients. 
Internalized 
Stigma measure: 
Modified scale 
based on the 
Berger scale 66  
Retention in 
HIV care: 
Medical record 
review 
Layer et 
al., 2014 
Tanzania Mixed-
methods 
48 HIV 
positive 
individuals 
in care 
Key barriers included 
the reluctance to engage 
in HIV services while 
healthy, rigid clinic 
policies, disrespectful 
treatment from service 
Internalized 
Stigma measure: 
Self report 
Retention in 
HIV care: Self 
report 
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providers, stock-outs of 
supplies, stigma and 
discrimination, alternate 
healing systems, and 
distance to health 
facilities and poverty. 
Tomori et 
al., 2014 
Tanzania Qualitative 14 HIV 
diagnosed 
individuals 
in care 
Participants reported 
significant barriers to 
retention, including, 
persistent stigmatization, 
and frequent reliance on 
alternative healing 
systems instead of 
biomedical treatment 
Internalized 
Stigma measure: 
Self-report 
Retention in 
HIV care: Self-
report 
Magnus 
et al., 
2013 
USA Cross 
sectional  
 
479 HIV 
diagnosed 
individuals 
in care 
A break in care was 
associated with 
perceiving that the 
doctor or health 
professionals do not 
listen carefully most or 
all of the time, having an 
elevated stigma score, 
and indicating that 
providers dislike caring 
for HIV-infected people. 
Women were more 
likely to have an 
elevated stigma score 
than men, as were 
participants over 30; 
those with a 
gay/bisexual orientation 
were less likely to have 
an elevated stigma score. 
Internalized 
Stigma measure:  
For this study 
they used a 
subset (14 items) 
of Sayles et 
al.28-item 
Internalized 
Stigma Scale. 67  
Retention in 
HIV care 
measure: Self 
report 
 
Earnshaw 
et al., 
2013 
USA Cross 
sectional 
95 HIV 
diagnosed 
individuals 
in care 
Internalized stigma was 
significantly associated 
with days in medical 
care gaps and ARV non-
adherence. 
Internalized 
Stigma measure: 
Modified scale 
based on the 
Berger scale 66  
Retention in 
HIV care 
measure: 
Medical record 
review 
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Pecoraro 
et al., 
2013 
USA Qualitative 41 HIV 
diagnosed 
individuals 
in care  
Dropping out of care 
was associated with 
drug/alcohol use, 
unstable 
housing/homelessness, 
psychiatric disorders, 
incarceration, problems 
with HIV medications, 
inability to accept the 
diagnosis, relocation, 
stigma, problems with 
the clinic, and 
forgetfulness.  
Internalized 
Stigma measure: 
Self-report on  
reasons for 
leaving and 
returning to HIV 
treatment 
Retention in 
HIV care 
measure: 
Medical records 
review and self-
report  
Lifson et 
al., 2013 
Ethiopia Qualitative 21 HIV 
diagnosed 
individuals 
in care  
Respondents reported 
multiple barriers in 
attending clinic 
appointments, including 
stigma and 
discrimination and lack 
of support. 
Internalized 
Stigma measure: 
Self-report 
(question 
assessing 
barriers to HIV 
care)” 
Retention in 
HIV care 
measure: Self 
report 
Dasgupta 
et al., 
2013 
India Cross 
sectional  
198 HIV 
diagnosed 
women in 
care.  
Higher levels of stigma 
were associated with 
lower CD4 count upon 
entry into care. Stigma 
was not associated with 
having missed scheduled 
HIV care appointments. 
Internalized 
Stigma measure: 
Modified scale 
based on the 
Berger scale66  
Retention in 
HIV care 
measure: 
Medical record 
review 
Smith et 
al., 2012 
USA Mixed 
Methods   
20 HIV 
diagnosed 
individuals 
in care 
Factors influencing 
retention in HIV care 
were related to stigma 
associated with 
comorbidities such as 
substance use and 
depression. Such 
Internalized 
Stigma measure:  
Self-report 
(question 
assessing 
barriers to HIV 
care) 
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experiences (e.g., shame, 
anticipated judgment 
from providers, viewing 
care attendance as 
incompatible with drug 
use), when identified by 
participants, 
significantly impacted 
their attitudes toward 
engaging in care. In 
particular, internalized 
stigma emerged as a 
critical barrier to care in 
this population. 
Retention in 
HIV care 
measure: Self 
report 
Russ et 
al., 2012 
USA Qualitative  17 HIV 
diagnosed 
in care 
Clients acknowledged 
that stigma is a severe 
barrier to access to care. 
Internalized 
Stigma measure: 
Self-report 
(question 
assessing 
barriers to HIV 
care) 
Retention in 
HIV care 
measure: Self-
report 
Wohl et 
al., 2011 
USA Cross 
Sectional 
398 HIV 
diagnosed 
individuals 
in care 
The major predictor of 
retention in HIV care 
was disclosure of HIV 
status to more social 
network members. More 
MSM-stigma was 
associated with poorer 
retention for Latino 
MSM. 
Internalized 
Stigma measure: 
 Validated 
Internalized HIV 
stigma scale 68  
Retention in 
HIV care 
measure: 
Medical record 
review 
Williams 
et al. 
2011 
USA Qualitative 25 HIV 
diagnosed 
individuals 
in care. 
Five themes emerged for 
barriers to remaining 
engaged in care once 
initiated: (a) the impact 
of competing demands, 
(b) aspects of the system 
of care, (c) the influence 
of stigma, (d) the 
experience of negative 
affect, and (e) various 
beliefs about the need 
Internalized 
Stigma measure: 
Self report 
(based on 
questions 
identifying the 
main facilitators 
and barriers to 
remaining in 
HIV care once 
initiated.) 
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for or role of HIV 
treatment. 
Retention in 
HIV care 
measure: Self 
report 
Kempf et 
al., 2010 
USA Qualitative 45 HIV 
diagnosed 
individuals 
in care 
residing in 
rural 
counties in 
Alabama. 
Factors that impacted 
participants' ability to 
maintain clinic visit 
appointments included 
personal, contextual, and 
community/environment
al factors that included: 
patient/provider 
relationships, family 
support, access to 
transportation, 
organizational 
infrastructure of the 
health care facility 
visited and perceived 
HIV stigma within their 
communities. 
Internalized 
Stigma measure: 
Self-report. 
Retention in 
HIV care 
measure: Self-
report 
Dietz et 
al., 2010 
USA Longitudinal 178 HIV-
infected 
female 
adolescents 
aged 13–24 
Controlling for ART 
status and CD4 counts, 
participant’s age, and 
number of scheduled 
appointments, marijuana 
use remained significant 
in multivariate analyses. 
HIV stigma subscales 
were not significantly 
associated with the 
outcome of interest. 
Internalized 
Stigma measure: 
Modified scale 
based on the 
Berger scale  
Retention in 
HIV care 
measure: 
Medical record 
reviews 
Rajabuin 
et al. 
2007 
USA Qualitative 76 HIV 
diagnosed 
individuals 
in care in 
six cities. 
Findings indicated that 
participants cycled in 
and out of care, a 
process that was 
influenced by (1) their 
level of acceptance of 
being diagnosed with 
HIV, (2) their ability to 
cope with substance use, 
mental illness, and 
stigma, (3) their health 
care provider 
relationships, (4) the 
presence of external 
Internalized 
Stigma measure:  
Self report 
(based on 
participant’s  
past experience 
with HIV 
medical 
care; current 
HIV medical 
care and barriers 
facilitators 
to retention in 
care) 
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Discussion 
We were not able to find a substantial number of studies that focused on the relationship 
between internalized stigma and retention in HIV care. The majority of the studies have been 
published in the last 5 years with 9 of the 17 studies published in the last 2 years, indicating how 
new this area of HIV research is, and how important it is becoming. The fact that the majority of 
the studies have a qualitative design also indicates that research in this area is in the exploratory 
phase.  
 
Themes 
From all the studies reviewed a majority (15 of the 17 studies) concluded that internalized 
stigma was a barrier to retention in care. Of the two studies that did not find an association 
between internalized HIV stigma and retention in HIV care one was conducted among HIV 
support systems, and (5) 
their ability to overcome 
practical barriers to care.  
Retention in 
HIV care 
measure: Self-
report 
Naar-
King et 
al., 2007 
USA Longitudinal 104 newly 
diagnosed 
Persons 
Living with 
HIV/AIDS  
Improvements in mental 
health status and the 
elimination of stigma as 
a barrier were not 
associated with 
retention, but those who 
reported stigma as a 
barrier at baseline and 
continued to report 
stigma at 6 months had 
less than adequate 
retention. 
Internalized 
Stigma measure: 
Single item 
question 
assessing 
perception of 
HIV stigma as a 
barrier to care  
Retention in 
HIV care 
measure: 
Medical record 
review  
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positive women in India,55 while the second study was conducted among adolescent women 
receiving HIV care in adolescent HIV clinics.58 
 
A recurrent theme that emerged from the literature review was that internalized HIV stigma is 
not associated with retention in care in isolation. Clinical care factors such as patient-provider 
interactions, clinic and treatment related issues, as well a patient level factors such a high risk 
behaviors, lack of social support and mental health issues are also important to consider when 
exploring the association of internalized stigma with retention in HIV care.  
 
Strengths and Weaknesses of Reports 
All of the studies in our analysis were based on sound qualitative or quantitative 
methodology. Five studies utilized validated internalized stigma scales, and seven studies 
assessed retention in care using medical record abstractions which are considered the gold 
standard for measuring retention in care. Only three studies in the United States, one focusing on 
men who have sex with men,57 a second one focusing on adolescent women,58 and the third 
among a sample of only 95 HIV positive patients,56 measured retention in care via medical 
records and utilized a validated stigma scale. The majority of the studies that measured retention 
in care via medical record abstraction  used visit constancy to assess retention in care, which 
according to Mugavero and colleagues is not the ideal measure of retention in care from a 
clinical or policy/administrative perspective.45   
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Limitations of the Review Process 
Our search of potential studies to include in this review was purposefully wide. We knew 
going into the search that the field was new and that all researchers might not be using the same 
terminology to describe their studies. This is clear when one examines the titles of the studies 
that ultimately were included in the review. As such, there was no narrower set of “key” words 
that would have identified all the reports in our analysis so our initial decision to be as broad as 
possible seems to have been the correct one. Having said that, additional searches using different 
combinations of words identified in the titles of the studies that ultimately were used in the 
analysis might have produced additional studies to include, so we can’t say that the studies in 
this review are the only ones assessing our outcome of interest. The use of snowballing (which 
identified 4 additional studies), mitigates in some way this weakness of the review process.  
 
Implications and Future Research 
The existing literature on the association of internalized HIV stigma with retention in 
HIV care is scant. Most of the articles have been published recently and are qualitative in nature; 
having said that, the evidence from this systematic review points to a relationship between 
internalized HIV stigma and retention in HIV care. The majority of the studies conducted in the 
United States with different patient populations and utilizing different methodologies reached the 
same preliminary conclusion. Still, more work needs to be done to clarify this relationship.  
Future studies need to use valid retention in care measures that will help us understand what role 
internalized HIV stigma plays in clinical management as well for policy making and resource 
allocation decision. Likewise, future studies should use validated internalized HIV stigma scales 
and include larger and more heterogeneous samples. Finally, HIV care and patient level factors 
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negatively correlated with retention in HIV care such as patient-provider interactions, problems 
with the clinic (such as appointment scheduling), problems taking HIV medications, poverty, 
drug use, lack of social support, high risk behaviors (such as alcohol and drug use), mental health 
issues (such as depression), and other stigmatizing conditions should also be assessed to 
determine how they impact the relationship between internalized HIV stigma and retention in 
HIV care .  
 
This dissertation, therefore, proposes to test the hypothesis that internalized HIV stigma 
is significantly associated with poor retention in HIV care among a diverse sample of HIV 
positive individuals. The study will also explore whether Internalized HIV stigma operates 
directly on retention in HIV care or if there are other covariates that moderate the relationship 
between internalized HIV stigma and retention in care. Ultimately, study findings will serve to 
inform HIV prevention and care policy in order to improve the lives of those affected by this 
disease. 
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CHAPTER 3: RESEARCH DESIGN AND METHODOLOGY 
 
Study hypotheses were tested in an observational, cross-sectional study, via secondary 
data analysis of interview and medical record abstraction data collected from a total of 194 HIV 
positive men and women who received care at the University of Miami/Jackson Memorial 
Hospital Special Immunology Clinics. Data was collected from August 2009 to May 2011 as part 
of a R21 study (Health Literacy, Cognitive & Social Determinants of HIV Appointment 
Attendance - R21 MH084814) funded by the National Institute of Mental Health (NIMH) that 
sought to explain the effect of low reading literacy for health-related information and 
neurocognitive impairment on poor adherence to appointments for HIV care.  
 
Description of the Health Literacy, Cognitive & Social Determinants of HIV Appointment 
Attendance Study 
 
Study Participants 
All participants were in HIV care with the University of Miami Jackson Memorial 
Hospital (UM/JMH) Special Immunology (SI) clinics at the time of enrollment. The UM/JMH is 
the largest medical provider in the area and serves the indigent and non-insured population of 
South Florida. At the time of the study the UM/JMH Infectious Diseases Clinic database 
characterized the patient population as follows: There were a total of 2559 unduplicated clients 
served in the SI clinics from 01/01/01 to 12/31/06. They represented a total of 8,855 total visits 
with an average of 700 visits per month to the clinic. Of those, 342 individuals were new to the 
34 
 
clinic. Gender characteristics of clinic patients included 62% men, 37% women, and 1% 
transgender. Racial/ethnic breakdown for clinic population included 58% Black, 29% Hispanic, 
7% Haitian, 8% White, and 1% other. Age distribution of clinic population included 1% ages 18-
24, 40% ages 25-44, 52% ages 45-64, and 6% age 65 & older.  
 
The research team had conducted studies with patients from this clinic for a number of 
years. Researchers had obtained excellent cooperation from clinic staff and strong interest in the 
studies from clinic patients in the past. No exclusions were made on the basis of antiretroviral 
use since the number of routine scheduled appointments was the same for those taking and not 
taking antiretrovirals. Researchers collected detailed locator information and participant’s 
permission during the informed consent process to continue to follow them during the 7 month 
study period. Those participants who relocated to another HIV care clinic during the course of 
the study remained eligible and were asked to provide written permission to contact their new 
HIV care provider in order to verify appointment adherence.  
 
Inclusion/exclusion criteria in this study included: 
1. Participation in a clinical trial- Patients from the UM/JMH SI clinics enrolled in a clinical trial 
were excluded. Clinical trial patients’ appointment-making and reminder procedures were 
different from routine clinic patients, thus limiting generalizability of findings. 
2. Major Psychiatric Illness - During screening, participants were asked questions from the 
Schizophrenia and Other Psychotic Disorders section of the Interview Guide for Evaluating 
DSM-IV Psychiatric Disorders and the Mental Status Examination to rule out a psychotic 
illness.69  The interview consisted of 12 questions related to delusions and hallucinations. Those 
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who respond yes to any of the questions, indicating the existence of a psychotic symptom, were 
excluded. 
3. Below 21 years of age – Participants had to be 21 years old and older (there is no upper age 
limit). The nature of cognitive functioning is different between children and adults and many of 
the tests used in this study were not appropriate for individuals under the age of 21. 
4. History of head trauma with loss of consciousness (LOC) > 15 minutes or other history of 
significant pre-existing brain disease.  Participants who reported ever having head trauma with 
LOC > 15 minutes were excluded due to the potential confounding cognitive effects of head 
injury. This exclusion criterion also excluded participants with a history of neurological disease 
resulting from or independent of HIV infection, which can also effect cognitive functioning.  
5. Inability to communicate comfortably in English - Approximately 29% of patients at the 
UM/JMH Infectious Diseases Clinic are Hispanic and 7% are of Haitian descent. However, the 
neuropsychological tests, psychosocial measures and normative data required for interpretation 
of the tests are limited for those who speak only Spanish and virtually non-existent for speakers 
of Creole. Therefore, all participants in this study had to communicate comfortably in English.  
 
Anticipated Number of Patient Appointments 
Procedures for routine HIV care at the UM/JMH SI clinics followed recommended 
guidelines during the study period.70 Patients are routinely seen every 3 months for laboratory 
assessments (e.g., HIV viral load, CD4 cell count) and for regular medical appointments with 
their physician. Those just establishing HIV care are seen 4 to 6 weeks after their initial visit. 
Those who are sicker are seen more often. The number of scheduled visits is the same whether or 
not the patient is taking antiretroviral medications. It was anticipated based on historical clinic 
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information that patients would attend an average of 4 visits per year. At the Infectious Diseases 
Clinics, appointments are written on an appointment card at the time of discharge from the 
current appointment. A mailed reminder is also usually given. Patients who miss appointments 
are not contacted and the patient is responsible for rescheduling a missed appointment.  
 
Recruitment   
Members of the medical teams within the Infectious Diseases Clinic (i.e., attending 
physicians, nurse practitioners, and physician assistants) who were involved in patient care 
approached patients in the clinics and determined their interest in learning more about the study. 
In addition, flyers describing general study information were posted in the clinic with contact 
information for the study recruiter. If members of the medical team determined that a particular 
patient was interested in learning more about the study, that patient was referred to the study 
recruiter who arranged to meet with the patient to discuss the study further. Clinic team members 
either brought the patient to the study recruiter for a brief pre-screening interview or they 
contacted her via cell phone and she conducted the pre-screening interview over the phone. All 
recruitment procedures were in compliance with HIPAA regulations. During the pre-screening 
interview, the patient was asked questions to determine if s/he met basic inclusion and exclusion 
criteria. For potential participants for whom English is a second language, researchers 
incorporated a simple assessment of English communication into the screening process to ensure 
that potential participants were able to communicate in English and comprehend the study’s 
evaluations.   
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Study Procedures 
Participants completed the baseline (T0) study procedures in one session. After obtaining 
informed consent, participants completed demographics information, a neuropsychological 
evaluation and psychosocial measures including those to assess social support and patient-
provider communication (all assessments are described in detail below). Researchers also 
obtained permission from participants to access their medical records in order to obtain 
verification of their attendance at scheduled HIV clinic appointments. Participants were 
compensated $40 upon completion of baseline procedures. 
 
Participants were then asked to complete a 2nd and final study session 7 months after 
completion of their baseline assessment. This 7-month follow-up assessment (T1) was to assess 
through self-report, attendance at HIV care appointments. Researchers also verified the self-
report through medical record abstraction.  Participants were paid $40 upon completion of the T1 
visit.  Researchers allowed a window period of +/- 2 weeks to complete the T1 study visit. The 
timeline of activities for the Health Literacy, Cognitive & Social Determinants of HIV 
Appointment Attendance study is reflected in Figure 7. 
 
A total of 325 individuals were screened for the study. The most common reasons for 
ineligibility were active psychiatric illness (hallucinations or delusions) or hospitalization due to 
head injury. A total of 8 individuals who were eligible for the study no-showed for their consent 
and baseline appointment and 15 were uninterested in participating after screening eligible.  
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Final Enrollment and Follow-up 
A total of 210 HIV positive persons meeting eligibility criteria and willing to participate 
in the study were consented prior to baseline study procedures. Since researchers anticipated 
many in the sample to be low literate or cognitively impaired, they included a post-test consent 
to verify comprehension of study procedures, risks, benefits, and other pertinent information. 
Only 1 individual was unable to complete the consent post-test and ultimately denied eligibility 
for the study. 
 
Note: This study was funded under the NIH R21 mechanism which provides two years of funding. 
NIH project start date was 5/6/2009 and NIH project end date was 4/30/2011. T0 is the baseline 
interview, the point at which participants were enrolled. T1 is the follow-up interview that occurred 
7 months post-baseline. Medical Chart abstraction was conducted retrospectively – only after 
enrollment into the study and was conducted for each participant at completion of T0 and again at 
completion of T1. 
 
As previously mentioned, participants who completed the baseline interview and 
assessment were scheduled for a follow-up appointment 28 weeks later. So as to not influence 
clinic appointment behavior, participants were not contacted until 24-hours prior to their follow-
up appointment. If they did not attend their follow-up they were mailed a reminder letter and 
attempts to contact the person by phone were made for up to two weeks. If after this time, 
Table 3. Timeline of R21 Study Activities 
May-June 2009 
July – 
Sept 
2009 
Oct – 
Dec 
2009 
Jan – 
Mar 
2010 
Apr – 
June 
2010 
July- 
Sept 
2010 
Oct – 
Dec 
2010 
Jan – 
Mar 
2011 
Apr   
2011 
Start-up 
activities 
T0 T0 T0 T0 T0    
   T1 T1 T1 T1 T1  
 
EMR 
audit T0 
visits 
EMR 
audit 
T0 
visits 
EMR 
audit T0 
visits & 
EMR 
audit T1 
visits 
EMR 
audit T0 
visits & 
EMR 
audit T1 
visits 
EMR 
audit T0 
visits & 
EMR 
audit T1 
visits 
EMR 
audit 
T1 
visits 
EMR 
audit 
T1 
visits 
Close 
out Data 
Analysis 
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researchers were unable to reach a participant he or she was considered lost to follow-up. Of the 
210 individuals enrolled at baseline, 194 completed follow-up interviews 28-weeks later. This 
reflected a 94% retention rate.  
 
Dissertation Approach and Design  
 
As described in Figure 7, for the purposes of the secondary data analysis conducted in 
this observational, cross-sectional study, de-identified interview data from the 194 participants 
who completed the follow-up data point (T1) will be used to describe the characteristics of the 
patient population including demographics, clinical care experiences, internalized stigma, social 
support, alcohol and drug use, and depression (see below for a more detailed explanation of 
potential independent variables). Moreover, de-identified medical record abstraction data will be 
used to describe clinic attendance patterns over the 14 month period of time preceding the 
interview.  
 
Figure 7. Data Collection timeline 
 
• T0 is the baseline interview, the point at which participants were enrolled. T1 is the follow-up interview 
that occurred 7 months post-baseline 
• Medical Chart abstraction was conducted retrospectively (7 months prior to T0) and prospectively (7 
months post T0) 
• The proposed study will test study hypotheses using a retrospective analysis of interview data collected 
at T1 and medical chart abstracted data collected from months -7 to 7. 
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Data Management and Analysis 
Dependent variable measures 
In order to measure retention in care for both clinical and policy/administrative purposes, 
we propose to use two constructs recommended by Mugavero and colleagues; one construct that 
reflects retention in care for clinical purposes and the other construct that  reflects retention in 
care for policy/administrative purposes.45 
 
To assess retention in care for clinical purposes we propose to use missed visits, which is 
a simple count of the number of scheduled visits that were missed (or “no-shows”), irrespective 
of the number of visits that were scheduled. We will measure this construct as a count or the total 
number of scheduled visits that were missed. This variable was named “missed visits.” 
 
To assess retention in care for policy/administrative purposes we propose to use the 
appointment adherence measure calculated as the percentage of total scheduled medical 
appointments at the outpatient SI clinics that were kept during the 14-month period. This 
variable will be named “appointment adherence” and will be reported as a continuous variable 
(0%-100%). 
 
As stated above, patients at the UM/JMH clinics were scheduled for a minimum of one 
regular physician appointment every 3 months (+/- 2 weeks). In the electronic patient medical 
record, each patient’s appointments were coded as “no-show”, “cancelled”, “rescheduled” or 
“checked-out” (indicating that the patient attended the visit). Visits classified as “no-show” were 
used for the missed visits construct measure, while appointments classified as “checked out” 
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were used for the appointment adherence construct measure (with the denominator being the 
total number of appointments scheduled that were not cancelled or rescheduled). Visits that were 
“cancelled” or “rescheduled” (either by the patient or the clinic) were not included in the two 
dependent variable measures.  
 
Independent Variable 
Internalized HIV stigma: The 13-item HIV Stigma Scale was developed by Sowell et al. 
71 and further validated by Emlet for use in older adults living with HIV/AIDS.68 During the 
initial development study, content validity was addressed by the active involvement of the target 
population during focus group discussions concerning item generation selection, and ease of item 
understanding.71 During the further validation study, the factor structure of the scale was defined 
and Cronbach’s alphas calculated for the overall 13-item scale (Cronbach’s alpha = 0.86). 
Construct validity was addressed and the correlations were as expected with higher scores 
representing higher levels of stigma. 
 
Covariates 
Social Support: We assessed available social support using a subscale from the Social 
Support Questionnaire developed by Zich and Temoshok.72 This scale consists of eight items that 
assess four types of support one may have received since becoming HIV positive. For each 
category of support, the person states how (1) desirable you believe this type of help/support 
would be for you at this time in your life, (2) how available this type of help/support would be if 
you wanted it, (3) how often you have experienced this type of help/support since you were 
diagnosed HIV?, and how useful this type of help/support has been when you did receive it. 
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Items are rated from 1 “not at all” to 5 “very much, constantly”. For this analysis, only the 
subscale that assessed “how often you have experienced this type of help/support since you were 
diagnosed HIV?” (#3 above) was used.   
 
Since depression has been consistently associated with medication adherence in HIV, the 
Center for Epidemiological Studies - Depression 10 (CES-D10) 73 was used to measure current 
depressive symptomatology. Item responses are rated using a Likert scale ranging from 0 (none 
of the time) to 3 (all of the time). Scores range from 0 to 30, a score of ≥10 is indicative of 
significant depressive symptoms. The CES-D has very high internal consistency, adequate test- 
retest reliability (r = 0.71) and well established validity across a wide variety of populations. 
 
Patient-Provider Relationship: The association of patient-provider relationship with 
retention in care was measured through the perceived quality of the relationship with providers. 
The quality of patient-provider communication will be assessed with the Engagement with 
Healthcare Provider Scale, a 13-item scale. Patients rate the nature of their interactions with 
providers on a scale where 1 = always true and 4 = never true. The scale was developed for use 
with HIV positive patients and shows good reliability.74 
 
Demographic and other patient characteristics: Study findings will be adjusted for 
demographic (e.g., gender, race/ethnicity, age, education, marital status) and other patient 
characteristics that may be associated with retention in HIV care. For example, we assessed 
sexual orientation, injection drug use (ever), time in HIV care, whether participant is currently 
taking ART, and time to travel to the clinic.  
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Power calculation 
Estimates of the prevalence of internalized stigma among HIV infected persons suggest 
that nearly 50% of these individuals report at least moderate levels of internalized stigma and 
about 25% report high to very high levels.68 Post hoc power analyses were conducted based on 
the sample size of 194 participants who completed follow-up activities in the study. First, power 
analysis was performed using GPower for a multiple linear regression on modeling the 
percentage of missed appointments in terms of the primary covariate of interest, HIV stigma 
score, and other 5 covariates from those listed above (time in care, # scheduled visits, age, 
marital status, time to travel to clinic) selected because of their association with retention in HIV 
care in previously published studies from this dataset. 75(Waldrop-Valverde et al., 2014). We 
considered three effect sizes for this assessment: small (f^2=0.02), moderate (f^2=0.15), and 
large (f^2=0.35) where f^2 represents Cohen’s f .76 The alpha level was pre-specified at 0.05 (2-
sided). The post hoc power analysis indicates that the statistical power for the detection of a 
moderate to large effect exceeded .99, and was 0.50 for detecting a small effect of 0.02. The 
multiple linear regression had 0.80 power for detection f^2 as large as 0.04.   Power analysis was 
then performed for a Poisson regression on modeling the probability of having missed visits in 
terms of the primary covariate of interest, HIV stigma score, and other covariates using the 
Power Analysis Sample Size (PASS) software. Based on the data, the probability of having 
missing appointments at the mean of HIV stigma score was set at 0.80.  We considered three 
effect sizes for this assessment: small (Odds ratio=1.5), moderate (Odds ratio=2), and large 
(Odds ratio=3), where the odds ratio correspond to the increase in the odds of having missing 
appointments when the HIV stigma score is increased to one standard deviation above the mean.  
The post hoc power analysis indicates that the statistical power for the detection of small, 
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moderate and large effects were 0.6, 0.97, >0.99, respectively, at the alpha level of 0.05 (2-
sided). 
 
Analysis 
Univariate analyses (ex. frequency, range, mean, standard deviation) will be conducted 
for all variables. The internal consistency of the HIV internalized stigma, social support, CES-D 
scale and other scales will be reported. Bivariate analyses will be conducted in order to examine 
factors related to each of the retention in HIV care outcome variables (Number of Missed Visits 
and appointment adherence). Given the categorical and count nature of some variables in this 
analysis associations between the retention in HIV care variables and independent variables was 
assessed using Spearman rank correlation. The statistical software (SAS) used to calculate the 
Spearman rank correlation automatically rank orders the data within variables.  Multivariable 
models included all independent variables identified in the Spearman rank correlation to be 
associated at p<.10 with the two dependent variables.  Given that the Number of Missed Visits 
variable is a count of the total number of scheduled visits that were missed, it will be examined 
in a multivariate Poisson Regression model. Multivariable linear regression (MLR) will be used 
to assess the association of internalized HIV stigma with retention in HIV care measured by the 
appointment adherence variable. After testing the association of internalized HIV stigma with 
retention in HIV care, and based on our theoretical postulation that internalized stigma may be 
negatively associated with patients’ perceptions of social interactions, including provider 
interactions, increasing vulnerability to poor health behaviors such as missing medical visits, we 
will test the engagement with provider construct as a moderator of the relationship between 
internalized HIV stigma and the two retention in care dependent variables. Overall statistical 
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significance for the two final models was set at p<.05. All statistical analyses were conducted 
using SAS 9.3. 
 
IRB Approval 
Ethics approval for the proposed research study was obtained through the Institutional 
Review Board at the University of North Carolina at Chapel Hill. 
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CHAPTER 4: RESULTS 
 
Sample Characteristics 
From the 194 participants that completed the follow-up interview six participants were 
removed for having missing data for at least one of the variables needed to calculate appointment 
adherence. Results from the analysis of the cross-sectional data indicate that fifty-four percent of 
the participants were female and forty six percent were male. The majority of the participants 
were forty five years or older. Fifty-five percent of the participants had never married and were 
currently single while thirty-one percent were divorced/separated/widowed. Only fourteen 
percent of participant were currently married or living with a partner. The majority of 
participants (83%) were African American, ten percent were Hispanic, five percent were white 
and three percent were of other racial/ethnic groups. Forty-eight percent of participants had less 
than a high school degree, thirty-four had a high school degree, and eighteen percent had some 
college education. The majority of participants (84%) considered themselves heterosexual while 
sixteen percent considered themselves homosexual or bisexual. Five percent of participants had 
been admitted to mental health care in past 14 months. Eighteen percent of participants had ever 
injected drugs, while fifty-five percent of participants had used alcohol or non-injection drug use 
in the past 14 months.  
 
In terms of characteristics related to participants’ HIV diagnosis and care, mean time of 
having been diagnosed with HIV was 12.6 years (standard deviation [SD] 7.4 years) with a range 
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of less than 1 year (some participants were recently diagnosed) to 37 years. Participants took an 
average of 43.9 minutes (SD 30.6) to travel to the clinic for their HIV medical appointments 
(although some participants reported up to 2 hours to get to the clinic). Ninety-five percent of 
participants reported taking antiretroviral medications. Because one fourth of viral load 
observations were missing, the possible effects of missing observations for viral load were 
evaluated by sensitivity analysis that compared the results of the model using all available data 
and using data that included imputed values for missing viral loads (derived using next-and-last 
imputation methods with viral load data gathered from participants’ longitudinal medical 
records). Imputed values were used in all analyses. Sixty percent of participants had undetectable 
viral load. Of the 188 participants, twenty-six participants or 14% of participants did not miss a 
medical care appointment during the study period. Mean number of missed appointments was 
3.7 (SD 3.4, range 1-16), while mean appointment adherence was 55% (SD 28%, range 2%-
100%). 
 
The 13-item HIV Stigma Scale used to assess internalized HIV stigma in our study had a 
good internal consistency reliability (Cronbach’s alpha = 0.880). Mean internalized HIV stigma 
score was 21.1 (SD 7.8). Only sixteen percent of the sample reported experiencing no stigma at 
all, while thirty-five percent of the sample scored higher than the mean.  Mean social support 
score for the sample was 32.3 (SD 7.0) with a range from 11 to 40. The Social Support 
Questionnaire scale showed good reliability in the current sample (Cronbach’s alpha = 0.887).  
The Center for Epidemiological Studies - Depression 10 scale, which was used to measure 
current depressive symptomatology in our sample had a good internal consistency reliability 
(Cronbach’s alpha = 0.827). Mean depression score for the sample was 10.1(SD 6.2). As 
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previously noted a score of ≥10 is indicative of clinically significant depressive symptoms. 
Based on this cutoff half of the sample had clinically significant depressive symptoms. Average 
score on the Engagement with Healthcare Provider Scale was 16.2 (out of a range of 13 to 44). 
Since lower scores reflect better engagement, overall this sample was quite engaged with their 
provider. In this sample, the Cronbach’s coefficient alpha for the Engagement with Healthcare 
Provider scale was good at 0.77. 
Table 4. Demographic and clinical characteristics for study participants (N=188) 
Characteristic (variable name) Frequency Percent (%) Range Mean (SD) 
Gender  
   Male  
   Female 
 
Age  
18-44 
45 and above 
 
Marital Status  
Never married/single 
Married/living with partner 
Divorced/separated/widow/widower 
 
Race/Ethnicity  
White 
Black 
Hispanic 
Other 
 
Education  
Grades 1-8 
Grades 9-11 
12 or GED 
Any college 
 
Sexual Orientation  
Gay/Bisexual 
Heterosexual 
 
Admitted to mental health care  
Yes 
No 
 
 
86 
102 
 
 
49 
139 
 
 
102 
27 
59 
 
 
9 
156 
18 
5 
 
 
20 
  70 
65 
33 
 
  
30 
158 
 
   9 
179 
 
  
46.0 
54.0 
 
 
26.5 
73.5 
 
 
54.5 
14.3 
31.2 
 
 
4.8 
82.5 
10.1 
2.7 
 
 
10.6 
37.5 
34.0 
17.5 
 
 
16.0 
84.0 
 
4.8 
95.2 
 
 
------ 
----- 
 
24-70 
----- 
----- 
 
 
---- 
---- 
---- 
 
 
---- 
---- 
---- 
---- 
 
 
---- 
---- 
---- 
---- 
 
 
---- 
---- 
 
---- 
---- 
 
 
------ 
------ 
 
47 (7.4) 
------ 
------ 
 
 
---- 
---- 
---- 
 
 
---- 
---- 
---- 
---- 
 
 
---- 
---- 
---- 
---- 
 
 
---- 
---- 
 
---- 
---- 
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Injection drug use ever  
Yes 
No 
 
Alcohol/non-injection drug use past 
 14 months 
Yes 
No 
 
Depression past 30 days  
 
Available Social Support  
 
Engagement with Healthcare  
Provider Scale 
 
Internalized HIV Stigma  
 
Time since diagnosis (days) 
 
Currently taking ART  
Yes 
No 
 
Time to travel to the clinic (minutes) 
 
Viral Load  
Suppressed 
Not Suppressed 
 
Number of Missed Visits 
 
Appointment adherence (percent) 
 
 
 
33 
155 
 
 
 
103 
85 
 
---- 
 
---- 
 
---- 
 
 
---- 
 
---- 
 
 
179 
9 
 
---- 
 
 
113 
75 
 
---- 
 
---- 
 
 
18.0 
82.0 
 
 
 
54.5 
45.5 
 
---- 
 
---- 
 
---- 
 
 
---- 
 
---- 
 
 
95.2 
4.8 
 
---- 
 
 
60.3 
39.6 
 
---- 
 
---- 
 
 
 
---- 
---- 
 
 
 
---- 
---- 
 
0-25 
 
11-40 
 
13-44 
 
 
13-46 
 
0-37 
 
 
---- 
---- 
 
3-120 
 
 
---- 
---- 
 
0-16 
 
2-100 
 
 
---- 
---- 
 
 
 
---- 
---- 
 
10.1(6.2) 
 
32.3(7.0) 
 
16.2(5.4) 
 
 
21.1 (7.8) 
 
12.6 (7.4) 
 
 
---- 
---- 
 
43.9(30.6) 
 
 
---- 
---- 
 
3.6 (3.4) 
 
55 (28) 
 
 
Results of the Bivariate Analysis 
Results from the Spearman correlation analysis indicated that number of missed visits 
was correlated at p<0.10 with gender and age, while appointment adherence was correlated at 
p<0.10 with, gender, age and engagement with Provider.
 5
0
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Results of the Multivariable Analysis 
Results from the multivariable regression analysis model indicate that the overall 
regression model was significant at p < 0.01. The linear model explained a significant amount of 
variance in appointment adherence (R2 = .09, p = 0.005) although the amount of variance 
explained (9%) was small. In adjusted analyses, gender was significantly associated with 
appointment adherence in the model (p = 0.019) with women attending significantly fewer 
scheduled medical appointments than men. Also, age was significantly related to appointment 
adherence (p = 0.006); participants 45 years and older attended a greater number of scheduled 
medical appointments than those younger than 45 years. Engagement with provider was not 
significantly associated with appointment adherence (p=0.254). In this model, internalized HIV 
stigma was not significantly associated with appointment adherence (p=0.915) neither was the 
interaction variable that explored whether engagement with provider moderated the relationship 
between internalized HIV stigma and appointment adherence (p= 0.102). 
 
Results from the Poisson regression analysis on missing visits count indicate that model 
explained a significant amount of variance in missed visits (R2  = .15, p <0.001) although the 
amount of variance explained (15%) was also small. The Poisson regression analysis on missing 
visits count indicate that the adjusted incidence rate ratio for gender (=1.749) is 74.9% higher for 
females than for males. Likewise the adjusted incidence rate ratio for individuals 18-44 years of 
age (=1.383) suggests that missing visits count is 38.3% higher for 18-44 year olds than for 
individuals 44 years and older. 
 
 
52 
 
Table 6. Linear Regression Model Assessing Factors Associated with appointment 
adherence 
 Univariate Model Multivariate Model 
Characteristics Mean Diff (95% CI) p value β (95% CI) p value 
     
Gender  0.0213*  0.019* 
Female vs Male -0.094 (-0.173, -0.014)  -0.095 (-0.176, -0.015)  
Age  0.0056*  0.006* 
18-44 vs 45 and 
above 
-0.126 (-0.215, -0.037)  -0.125(-0.214, -0.034)  
Engagement with 
Provider 
 0.4828  0.254 
per score increase 
-0.003 (-0.010, 0.005) 
 
 -0.025 (-0.052,0.001)  
Internalized HIV 
Stigma 
 
0.9290 
 
 
0.915 
 
per score increase 
0.001 (-0.005-0.005) 
 
 
-0.015 (-0.034, 0.004) 
 
 
HIV Internalized 
Stigma x 
Engagement with 
Provider 
   0.102 
 (per stigma score 
increase) 
  
0.001 (-0.001, 0.002) 
 
 
Note: Variables associated with appointment adherence and Number of Missed Visits at 
p<.10 in the Spearman Correlation analysis are included in the model as well as 
Engagement with Provider.   
 
 
Additionally, the relationship of internalized HIV Stigma and Missed Visits is moderated 
by engagement with provider (p=0.003). Results of this moderating effect are shown for pre-
specified values that present scenarios when internalized HIV stigma is equal to the first, second 
or third quartiles. For subjects with low HIV stigma, the effect of engagement with provider is as 
follows: every one-unit increase in the engagement score (meaning lower engagement with the 
provider) is associated with 3.3% increase in missed visits incidence rate. For subjects with 
median HIV stigma, the effect of engagement with provider is as follows:  every one-unit increase 
in the engagement score (meaning lower engagement with the provider) is associated with 1.8% 
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increase in missing visits incidence rate. For subjects with high HIV stigma, engagement with 
provider is not significantly associated with Missed Visits. 
 
Table 7. Multivariate Poisson Regression Model Assessing Factors Associated with Number 
of Missed Visits 
Characteristics aIRR 95% CI p value 
Gender   <0.0001 
    Male Ref Ref  
    Female 1.739 1.480-2.045  
 
Age 
  
 
<0.0001 
    18-44 1.388 1.185-1.626  
    45 and above Ref Ref  
Internalized HIV Stigma 1.053 1.012-1.096 0.009 
Engagement with Provider 1.090 1.033-1.150 0.001 
Internalized HIV Stigma * Engagement 
with Provider 
0.996 0.994-0.999 0.004 
    
Engagement with Provider:     
Low Internalized HIV Stigma 1.033 1.013-1.053 0.001 
Medium Internalized HIV Stigma 1.018 1.004-1.032 0.010 
High Internalized HIV Stigma 0.9969 0.980-1.014 0.724 
Note: Variables associated with appointment adherence and Number of Missed Visits at p<.10 
in the Spearman Correlation analysis are included in the model as well as Engagement with 
Provider.  aIRR: adjusted Incidence Rate Ratios 
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CHAPTER 5: DISCUSSION 
 
Addressing Central Questions 
In order to address its central question of how internalized HIV stigma affects retention in 
HIV care, this study examined two key Aims: 
(1) Assess the association of internalized HIV stigma with retention in HIV care measured 
for clinical (missed visits), and policy making (adherence). 
(2)  Assess whether engagement with provider or other construct moderates this association. 
In terms of the first Aim we utilized two retention-in care measures that have been recommended 
for use in clinical and policy making decisions.  One of the variables assessed retention in care 
via missed visits while the other assessed retention in care from the opposite perspective of 
appointment adherence (or appointments kept). Although we found that both retention in care 
measures were significantly correlated to variables such as age and gender, our findings from the 
bivariate and multivariable analysis indicate that there is not a direct association between 
internalized HIV stigma and either of the retention in HIV care measures assessed in this study, 
which rejects one of the hypothesis of our study. 
 
In terms of the second question, the multivariable analysis indicated that engagement 
with provider moderated the association between internalized HIV stigma with retention in HIV 
care. Engagement with provider was also hypothesized to serve as a moderator between 
internalized HIV stigma and retention in HIV care, according to our Labeling Theory Modeling 
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the Association of Internalized HIV Stigma with Retention in HIV Care. As conceptualized, the 
expectation and fear of rejection, which is a product of the internalized HIV stigma, would lead 
the individual to withdraw or avoid potentially threatening social interactions (interactions where 
the stigmatized condition is revealed). Because the patient–provider social interaction is an 
unavoidable step that every HIV infected individual has to go through, the perceived quality of 
the relationship with providers was hypothesized to moderate the degree in which internalized 
HIV stigma affects HIV care behaviors that promote or hinder retention in HIV care. Results 
from our analysis looking at missed medical appointment visits confirmed that engagement with 
provider moderates the relationship between internalized HIV stigma and retention in care. Our 
findings indicate that engagement with provider is associated with reducing missed visits in 
patients reporting low to medium levels of HIV stigma. However, for participants with high HIV 
stigma, the perceived quality of the relationship with providers is not associated with reductions 
in missed visits.  To our knowledge, this is the first time that such a finding has been reported in 
the literature of retention in care and has important implications in terms of patient care.  
 
Although not related to retention in HIV care, a similar finding was reported by Katz and 
colleagues in their meta-analysis that assessed the impact of HIV-related stigma on antiretroviral 
treatment (ART) adherence.77 Not only did the results of the meta-analysis confirm that HIV-
related stigma negatively impacted participants’ abilities to successfully adhere to ART, but it 
also identified several intrapersonal, interpersonal and structural levels in which this happened. 
One of the main themes from their analysis identified different aspects of the health system (both 
interpersonal and structural) as potentially moderating the impact of HIV-related stigma on ART 
adherence. One of these aspects referred to the nature of interpersonal relationships between 
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patients and providers and how these relationships could foster better treatment adherence. Their 
qualitative findings in this area focused on the concept of “compassionate human capital 
elements,” which includes having doctors and nurses engaged in patient-centered care in order to 
establish bonds of trust and empower patients to overcome the stigma associated with taking 
medications. Katz and colleagues referred specifically to the perceived quality of the relationship 
with providers as key to foster better treatment adherence.77  
 
Findings from this dissertation, like those by Katz and colleagues, indicate the 
importance of developing interventions that strengthen interpersonal patient - provider 
relationships in order to moderate the association of low to moderate levels of HIV internalized 
stigma on retention in HIV care. However, for patients experiencing high levels of internalized 
HIV stigma, provider relations may not moderate missed visits. For these patients the challenge 
is to reduce internalized HIV stigma to low/moderate levels so that better provider relations can 
help to decrease missed visits. 
 
Of note, this was a cross-sectional observational study and the sample was comprised of 
an older population with a higher proportion of women and African-Americans than either the 
clinic caseload or the total U.S. HIV patient population. This limits the generalizability of these 
findings to other HIV infected patient populations beyond those showing the characteristics of 
our sample. On the other hand, our analysis indicated that 86% of participants in our sample 
reported missing one or more scheduled medical appointments. As previously noted, these 
scheduled appointments did not include those that were re-scheduled or cancelled; such a large 
proportion of missed scheduled visits is problematic from a clinical perspective. Other studies 
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have noted rates of 60% - 68% missed visits,15,48 suggesting that missed visits rates among our 
sample were higher than among other patient populations. Furthermore, a recent national 
analysis reporting levels of HIV infected patients engaged in care, prescribed antiretroviral 
treatment (ART), and virally suppressed reported that 82% of those prescribed ART were virally 
suppressed.78 However, only 60% of participants in our sample prescribed ART were virally 
suppressed, this implies that patients in our sample were less virally suppressed compared to the 
national estimates.  Both of these findings indicate that our sample was comprised of individuals 
with poorer retention in care practices and poorer clinical outcomes than other patient 
populations, precisely the type of patient population that would benefit from interventions to 
improve retention in care.    
 
Our findings suggest that for a patient population that reflects the characteristics of our 
sample (i.e. with poor retention in care practices, and poor clinical outcomes), implementing 
interventions that improve engagement with providers may be a good approach for those with 
low and medium internalized HIV stigma, but interventions to reduce internalized HIV stigma 
also need to be considered for those experiencing high levels of internalized HIV stigma. 
 
Improving Engagement with Provider 
Research in the area of improving patients’ engagement with and trust in doctors or a 
group of doctors has been going on in different disciplines for many years and has taken different 
forms. Rolfe and colleagues examined in a Cochrane Review ten randomized controlled trial 
interventions that focused on physician training, education for patients and interventions were 
patients were provided additional information about doctors in terms of financial incentives or 
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consulting style, all aiming at improving patients’ relationships with their medical providers.79 
Among all the interventions assessed only 3 (one provider focused and two patient focused) 
proved to be effective.  In project SCOPE, Tulsky and colleagues evaluated whether oncologists 
who received a CD-ROM training program on communication skills, that had examples of their 
own audio-recorded clinic visits would improve the providers’ ability to empathize with negative 
emotions expressed by cancer patients.80 The hypothesis was that improvements in 
communication skills would also result in increased trust. 
 
 Findings showed that patients whose oncologists were in the intervention group reported 
higher trust in their oncologists than patients whose oncologists did not receive the CD-ROM 
training (p = 0.036). Patients in the intervention group also reported significantly greater 
perceived empathy and a greater sense that their medical provider understood them in a holistic 
manner. Tulsky also reported that providers in the intervention group used significantly more 
empathic statements and were significantly more likely to respond to negative emotions 
empathically than the providers in the control group.80 
 
Clancy and colleagues evaluated the effects of Managed Care, in the form of group 
educational visits, on underinsured or uninsured patients with type 2 diabetes.81 The intervention, 
delivered by a physician and a nurse practitioner focused on a monthly 2 hour group session 
where presentations related to health-related topics, prevention activities, and one-on-one 
consultations took place. The authors found that overall there was a significant increase in the 
total trust score for the patients who attended the group visits compared to those who received 
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usual care. The authors also stated that significant positive increases occurred in the patients’ 
perception of coordination of care, community orientation and cultural competency.  
 
Finally, in Patient Choice, Hsu and colleagues matched patients seeking a new primary 
care provider (PCP) and practitioners based on beliefs about care.82 The investigators either gave 
patients the option to choose a provider or assigned a provider based on patient and provider 
preferences for shared decision making. The study also explored the effect of the intervention on 
patient satisfaction and patients’ perception of the process. Findings demonstrated that 
intervention subjects were more likely to retain their primary care provider at 1 year, and to 
report greater overall satisfaction with the PCP, compared to control subjects who were assigned 
to a PCP. The intervention subjects also reported greater trust in their PCP on most measures and 
reported a significantly increased perception that their clinician knew them well. 
 
Reducing Internalized HIV Stigma 
Our findings indicate that for patients experiencing high levels of internalized HIV 
stigma improving patient provider relationships might not be enough to reduce missed visits. For 
these individuals the best approach would be to reduce the high levels of internalized HIV stigma 
to medium or low levels so that interventions that improve patient provider engagement may 
work to improve retention in HIV care. In order to identify interventions that reduce internalized 
HIV stigma, we conducted a literature search of evidence based interventions that have been 
found to reduce internalized HIV stigma. Our search found 3 interventions that have been tested 
in the last few years that targeted specific groups and that have reported positive outcomes in 
terms of reducing internalized HIV stigma. Barroso and colleagues, developed an intervention 
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targeting minority women in the Southeastern United States that included a 45-min video titled, 
‘‘Maybe Someday: Voices of HIV-Positive Women’’ based on a protocol for the systematic 
integration of findings of qualitative studies conducted with HIV-infected women in the United 
States.83  The main points of the intervention were to “include the experience of being an HIV-
infected women; the fear of the negative social effects that come with telling other people about 
one’s HIV status; women’s tremendous struggle about whether or not to tell their children; the 
importance of communicating with nurses, doctors, and those family members and friends whom 
they trust; the positive effects of disclosure; the extra stigma and discrimination connected with 
being a woman, being a minority woman, and being a mother; and ambivalence about disclosing 
one’s HIV status to potential and actual sex partners.” Finding from their randomized controlled 
trial indicated that the intervention was successful in improving self-esteem and decreasing 
internalized stigma, as well as improving coping self-efficacy.   
 
A second intervention, also targeting minority women, developed by Rao and Colleagues 
84 modified the HIV Stigma Toolkit developed by the International Center for Research on 
Women (ICRW), the Academy for Educational Development, and the International AIDS 
Alliance, 85 to reduce public stigma in global settings. The toolkit which includes modules that 
provide individuals infected with HIV the skills to cope with internalized HIV stigma was 
modified to be applicable to African American women living with HIV infection in the United 
States and pilot tested during a workshop where the researchers measured changes in internalized 
stigma before and after workshop participation. Results of their pilot intervention showed that 
the intervention was feasible, and led to statistically significant reductions in internalized stigma 
from the start of the workshop to the end. 
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Finally, the intervention developed by Harper and colleagues focused on adolescents and 
young adults newly diagnosed with HIV and sought to reduce four dimensions of HIV-related 
stigma—personalized stigma, disclosure concerns, negative self-image, and concern with public 
attitudes about people with HIV.86 The intervention, tested in a pilot study, was based on the 
Disability- Stress-Coping model, 87 which theorizes that that risk and resistance factors work 
together to impact how adolescent’s adapt to chronic illness and/or disability. Risk factors 
included in the model focus on disease/disability parameters, functional independence, and 
psychosocial stress, while resistance factors fall into intra-personal, socioecological, and stress-
processing. Findings from this pilot study revealed overall reductions in stigma in three 
dimensions: personalized stigma, disclosure concerns, and negative self-image although results 
varied by gender; with males showing long term (3 month) decreases among all dimensions, 
while females only showed a post-intervention decrease for personalized stigma.    
 
Improving Retention in HIV Care 
In addition to interventions that increase patient – provider engagement and to reduce 
internalized HIV stigma, it is also important to focus on interventions that increase retention in 
care, as a way to address the fact that for patients reporting high levels of stigma the engagement 
with provider interventions and/or the interventions to reduce internalized HIV stigma might not 
work as effectively. Gardner and colleagues recently published the results of a multi-site 
randomized controlled trial that sought to determine whether enhanced personal contact with 
HIV infected patients across time improves retention in care.88 Their findings indicate that their 
intervention, which focuses on having a dedicated staff that is trained in case management 
techniques and maintains personal contact with patients with a history of missed visits, improves 
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retention in HIV primary care. This important finding coupled with findings from a meta-
analysis conducted by Higa and colleagues where the authors concluded that other low cost 
evidence-informed strategies such as displaying posters and brochures in waiting rooms, and 
having medical providers present brief messages to patients are also effective in retaining 
patients in care; 89 provide a wide array of alternatives to strengthen efforts to maintain UM/JHM 
patients engaged in care. These low cost interventions were even found to be cost effective 
generating a net-positive effect on clinic revenue of +$24,000/year for an average-size clinic 
(7400 scheduled visits/year).90  
 
Limitations 
The findings from the present cross-sectional observational study are subject to several 
limitations. First, study participants were a convenience sample recruited from the University of 
Miami Jackson Memorial Special Immunology clinics located in Miami, Florida therefore they 
are not representative of the larger population of HIV/AIDS patients at the UM/JHM clinics,  
Florida or the rest of the United States. At best our sample may reflect experiences of HIV 
infected individuals attending publicly funded health facilities who have similar characteristics. 
Second, our analysis focused mostly on patient-level predictors of visit adherence and missed 
visits. Potentially important health care structural-related characteristics that may also impact 
scheduled appointments were not assessed. Some important individual level characteristics such 
as self- efficacy were not assessed in this study even though these constructs have been related to 
retention in care in previous work.91 The potential effect of self-efficacy as a moderating 
construct between internalized HIV stigma and retention in care should be further explored. 
Findings from the missed visits and appointment adherence models indicated that although the 
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variables included in the models significantly explained 15% and 9%, respectively, of the 
variance of these retention in care measures, the variance was small signifying that other 
constructs need to be assessed to fully understand what impacts retention in HIV care. This study 
only included patients who were currently receiving HIV care; there may be a significant 
proportion of individuals with HIV who have high internalized HIV stigma who may have 
entered care at the UM/JHM clinic at some point but were lost to follow-up (never returned for 
appointments).  As described in Link’s Labeling Theory and our own Modified Labeling Theory 
(3rd step on both), these individuals are those with internalized HIV stigma whose coping 
response is to go in “secrecy” or “withdrawal”.  These findings would not be applicable to this 
group of individuals.  Finally, some data for HIV viral load was imputed due to missing data. 
This may have underestimated a possible relationship with the retention in care variables and/or 
overestimated levels of viral load suppression.  
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CHAPTER 6: PLAN FOR CHANGE 
 
Organizational and Policy Changes 
This dissertation explored the mechanisms by which internalized HIV stigma is 
associated with retention in HIV care in order to develop interventions that ultimately would 
contribute to achieve one of the objectives of the National HIV/AIDS Strategy, i.e. maintaining 
HIV infected individuals in care. Internalized HIV stigma is one of several factors that 
contributes to poor retention in care, but as we tried to assert in this dissertation, we believe as 
Bruce Link and others believe, that understanding the mechanism by which internalized HIV 
stigma is associated with poor health outcomes is important in order to improve those health 
outcomes. Findings from this dissertation of how 1- internalized HIV stigma doesn’t impact 
directly on retention in HIV care, 2- that the patient - provider relationship moderates the 
association of low to moderate levels of HIV internalized stigma on retention in HIV care, and 3- 
that for patients experiencing high levels of internalized HIV stigma, the patient - provider 
relationship may not moderate missed visits, provide important information on the mechanism 
by which internalized HIV stigma is associated with poor retention HIV in care. The expectation 
is that these findings will contribute to address retention in HIV care among the patient 
population of the Special Immunology Outpatient Clinics at Jackson Memorial Hospital, one of 
the largest clinics treating HIV patients in the southeast of the United States. The clinic is located 
in Miami, Florida which in 2013 ranked number 1 in the nation in terms of the rate (per 100,000 
population) of reported HIV diagnosed cases.92 
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Based on the findings and limitations of our analysis, the literature regarding improving 
engagement with provider, reducing internalized HIV stigma, and improving retention in care, 
and the feedback from my Dissertation Committee members, I decided to focus the activities in 
the plan for change on a three-prong approach.  
 
First, in an effort to address those individuals most affected by retention in care issues 
and considering that average appointment adherence was 55% in our sample (i.e. patients in our 
sample attended on average 55% of their scheduled appointments) to recommend that all patients 
who miss 50% or more visits in the past 12 months be screened for internalized HIV stigma. We 
prefer to use this measure for screening purposes given that it takes into consideration both the 
number of visits scheduled and missed, since concerns that a person who misses his/her only 
scheduled visit and the person who misses 1 of 4 visits would have the same number of missing 
visits (1) despite being different situations (with 0% attendance vs. 75% attendance). This will 
also help to identify among the UM/JHM clinic patient population individuals that may have 
retention rates similar to those in our sample that could benefit most from the proposed 
interventions.  
 
Second, after screening and identifying individuals with low, moderate and high 
internalized HIV stigma levels, we will recommend offering a patient focused patient-provider 
engagement intervention to those clinic patients reporting low to moderate levels of internalized 
HIV stigma to potentially improve retention in care rates among this group as our findings 
indicate. We will also recommend offering an internalized HIV stigma intervention to reduce 
internalized HIV stigma to clinic patients reporting high levels of internalized HIV stigma. Once 
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the internalized HIV stigma levels are reduced to medium or low levels among these patients, 
these patients will also be offered the patient focused patient-provider engagement intervention 
to potentially improve their retention in care rates.  Although, the success of this approach will 
need to be evaluated. 
 
Finally, Gardner’s low cost retention in care intervention Stay Connected, which has been 
found to improve clinic attendance will also be recommended.90 Although this intervention has 
not been tested in terms of its effect on individuals reporting low, medium or high levels of 
internalized HIV stigma, the intervention focuses on repeated messages coming from different 
sources (doctors, nurses, posters in clinics, brochures, etc.) regarding the importance of 
maintaining medical appointments. This intervention has been proven to be effective, especially 
for patients that at some point withdrew from care. Given that the models tested in this study 
explained little of retention in care, it is recognized that other factors remain to be identified. 
Broad-based interventions that have been shown to improve clinic attendance are also important 
to include. Moreover, this low cost intervention has also proven to be cost effective,93 which may 
serve to offset the costs of the engagement with provider interventions in the long run.   The 
success of this and other interventions will have to be evaluated. 
 
Strategy to Achieve Organizational and Policy Change 
Part of our strategy to promote the organizational changes described above is to use  
John Kotter’s 8 Steps Leading to Organizational Change.94 Kotter’s model visualized in Figure 9 
emphasizes 8 sequential steps that leaders need to implement to achieve changes in 
organizations.  
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Figure 8. Kotter’s Eight Step Change Model 
 
 
 
The first step in Kotter’s process is to “establish as sense of urgency”. In order to 
establish a sense of urgency at the UM/JMH clinics we will present the findings of this 
dissertation to all the staff at the SI clinics. The objective of the presentation will be not only to 
present the data regarding the high proportion of missed visits and the findings of how 
internalized HIV stigma affects retention in care when it is moderated by provider engagement, 
but also to open an honest and convincing dialogue about what's happening at the SI clinics, 
including possible solutions to the problem. The purpose as described by Kotter is to have the 
staff at the SI clinics to start talking about the proposed changes so that the urgency can build 
and feed on itself. Final decision on what strategies/interventions to be used in our efforts to 
reduce internalized HIV stigma and improve retention in care among UM/JHM clinic patients 
will be made after presentation of our findings to UM/JHM clinic staff, and consultations with 
the UM/JHM clinic leadership, patient advocates, and members of the guiding coalition. 
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The second step according to Kotter is to “create a guiding coalition”. Our efforts here 
will be to focus on recruiting leaders at the UM/JMH clinics, but given the importance that the 
UM/JHM clinics have in terms of patient care (and potentially prevention activities) at the 
county level, we will also try to recruit selected HIV prevention and care leaders in Miami-Dade 
County. 
 
One of the dissertation committee members is Dr. Allan Rodriguez who is the 
Operational Director of the Special Immunology Outpatient Clinics at JMH and the Director of 
the Behavioral/Social Science & Community Outreach Core of the Miami CFAR. We will ask 
Dr. Rodriguez to champion the organizational change at the UM/JMH SI clinics. His leadership 
and support will be essential to promote the changes that will improve retention in care at the 
UM/JMH SI clinics. 
 
A second member from the UM/JHM leadership that will be tapped  with Dr. Rodriguez’ 
help is Dr. Michael  Kolber who is the Director of the Comprehensive AIDS Program, Clinical 
Director of the Adult HIV Section for Infectious Diseases and Professor of Medicine at the 
University of Miami Miller School of Medicine.  As Director of the Comprehensive AIDS 
Program, Dr. Kolber interfaces directly with both community and state services and entities that 
provide or support HIV-related activities. He established the Infectious Diseases Research Unit 
and has oversight for HIV inpatient and outpatient clinical functions.  
A third individual who will be tapped to become a member of the guiding coalition is Ms. 
Villamizar who is the Director of the HIV/AIDS Program of the Miami-Dade County Health 
Department (MDCHD). I have worked with Ms. Villamizar for many years and we are close 
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friends. The prevention aspects of improving retention in care in Miami-Dade County is 
something that her office will strongly support.  I have no doubt that she will support our plan 
and become an active member of our guiding coalition. We will ask Ms. Villamizar to set a 
meeting with Ms. Michelle Wyatt, who is the current Chair of the Miami-Dade HIV/AIDS 
Partnership (The Partnership). The Partnership is the official county planning board for 
HIV/AIDS care services. It obtains input on community needs, sets priorities and allocates funds 
for Ryan White Part A/MAI, and makes recommendations for Ryan White Part B, General 
Revenue and Housing Opportunities for People with AIDS. In addition, it serves as an advisory 
board to the Miami-Dade County Mayor and Board of County Commissioners. The UM/JHM 
Clinics is one of the largest recipients of Ryan White funds in Miami-Dade County.  
Dr. Wyatt’s role as a leader in HIV care and treatment issues in Miami-Dade County will make 
her a valuable member of the guiding coalition.  
 
These four members of the guiding coalition will also be key to refine the plan for 
change, including the selection of the patient-provider and internalized HIV stigma interventions 
so that the plan for change better reflects the needs in terms of retention in care of the UM/JHM 
clinic patient population.  
 
The third step in Kotter’s process is to “create a vision for change”. All the members of 
the guiding coalition are familiar with the stakes. As previously described, the problem of failing 
to retain individuals in consistent HIV care has negative prevention and clinical consequences. 
How to address the problem regarding retention in care has proven to be more elusive. Our 
vision for change involves mitigating the impact of internalized HIV stigma on retention in care 
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by reducing high levels of internalized HIV stigma, and partnering patients and providers to 
address the problem, utilizing proven interventions that work at different levels. The vision will 
be synthesized in succinct messaging that captures what the guiding coalition sees as the future 
of the HIV prevention and care activities in Miami-Dade County: The burden of HIV in Miami-
Dade County is significant and making sure that patients receive timely treatment is a priority to 
improve clinical outcomes, prevent new infections, and minimize the impact of HIV in our 
community. The best way to achieve this goal is to reduce stigma and for patients and providers 
to work together.   
 
The next step according to Kotter is to “communicate the vision.” In addition to creating 
and posting messages within the UM/JMH SI clinics, and seeking every opportunity to present 
the dissertation findings and plan of action at the UM/JHM clinics (ex. medical rounds, SI clinic 
staff meetings, etc.), the plan will be communicated at a larger scale. With assistance of Ms. 
Villamizar we will reach County Commissioner and Chairman Jean Monestime from District 6.  
Commissioner Monestime has previously supported HIV/AIDS prevention and education 
initiatives in his district and has been the sponsor of several presentations of HIV prevention and 
care experts in front of the Miami-Dade County Commission in efforts to keep the County 
Commissioners updated on HIV care and prevention issues impacting citizens of Miami-Dade 
County. The Miami-Dade County Commission oversees the County’s Ryan White program so 
making them aware of our findings at one of the largest funded Ryan White clinics in the county 
is important.  
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In addition, to ensure a wide dissemination of our proposed plan to increase the rate of 
patients that keep their medical appointments at the UM/JHM clinics we will seek the support of 
media health reporters. The Miami Herald (MH), which is the newspaper that has the largest 
circulation in the Miami area, has a strong health reporting section led by Ms. Amy Driscoll who 
has been very active in reporting health issues in South Florida. We will meet with her and her 
staff to present them with the same information that we presented to the UM/JHM clinic 
leadership and solicit their support by writing a piece on the high burden of HIV in Miami-Dade 
County and the negative impact of low retention rates on patients’ health.   
 
The fifth step on Kotter’s model is to “empower people to act on the vision”. Our 
selection of change leaders will assure that we have a broad coalition that allows us to put in 
place the vision for change, and continually check for gains and barriers to achieving the desired 
vision.  Part of our activities to empower leaders to act on the vision is to allow them to address 
potential obstacles and make sure that they address any resistance in a quick manner. For 
example, although some providers might at first oppose to patient-provider engagement 
intervention, with the assistance of Dr. Rodriguez we will educate the providers of why 
improving patient-provider relations will improve job satisfaction and achieve better health 
outcomes for their patients. Other activities to empower individuals include selecting key 
members of the guiding coalition to be spokespersons of the plan for change. For example, 
members of the guiding coalition will present our strategy for reducing internalized HIV stigma 
and improve retention in care rates at the UM/JMH SI clinics at various community settings that 
are served by UM/JHM hospital. Finally, with the assistance of the members of the guiding 
coalition at the UM/JMH clinics other individuals within the UM/JMH clinics will be selected to 
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serve as additional champions so that activities to promote change are disseminated at several 
layers of the organization. 
 
The sixth step of Kotter’s model is to “create short-term wins.” Our first priority will be 
to get the patient-provider engagement intervention up and running at the UM/JHM clinics. 
Implementation of this intervention will signal that the combined patient-provider partnership to 
improve the retention in HIV care in Miami-Dade County has commenced. Even though the 
benefits won’t be seen for a while, the beginning of this patient-provider partnership will be seen 
as a symbolic step, galvanizing those affected by HIV (patients and providers) in order to work 
together to address stigma, strengthen patient-provider relationships, retain patient in care, 
improve patient outcomes, and minimize the impact of HIV across Miami-Dade County. The 
target is to have this intervention up and running within 6 months after the plan has been 
approved by the UM/JHM clinic leadership and members of the guiding coalition.  
 
The seventh step according to Kotter is to “build on the change.” In order to build on the 
change we need to conduct a thorough process evaluation to understand how intervention 
activities are being implemented and if they are achieving the desired outcomes. The evaluation 
will allow us to identify what processes are working and which ones are not, providing timely 
information to continuously improve processes.  
 
Given the three-prong approach (screening for internalized HIV stigma, interventions to 
reduce internalized stigma and improve patient and provider engagement, and structural retention 
in care intervention) the expectation is that even those patients reporting high levels of 
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internalized HIV stigma will benefit by seeing their stigma levels reduced which should facilitate 
the effect of the patient-provider engagement interventions to improve retention in care, but if 
that is not the case, the next level of evaluation will be to assess factors that potentially moderate 
the relationship between those individuals reporting high levels of internalized HIV stigma and 
missed visits. For this analysis, I looked at social support as a potential moderator (data not 
shown), hypothesizing that social support might better moderate the relationship between 
internalized HIV stigma and missed visits, but I found no significant relationship between social 
support and missed visits. Other constructs, such as self-efficacy would need to be explored.  
 
Finally, if the interventions at the UM/JHM clinics produce the desired effect, full 
implementation of these interventions county-wide might be warranted. We will work with the 
Partnership to identify Ryan White clinics with poor retention in care rates (and similar patient 
characteristics) where interventions as the ones proposed at the UM/JMH SI clinics might help in 
improving retention in care rates. 
 
The eight and last step according to Kotter is to “institutionalize the change.” As Kotter 
describes it, to make the changes permanent they must become a core part of the organization (or 
the system). To accomplish this we will disseminate widely the progress in mitigating the impact 
of internalized HIV stigma on retention in care by reducing high levels of internalized stigma 
and forging strong patient – provider partnerships, and how these partnerships are allowing to 
improve retention in care rates at UM/JHM clinics. This progress will be touted to UM/JHM and 
Partnership leaders as well as County Commissioners so they continue to support the change. 
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Every effort will be made to publicly recognize key members of the change coalition, and make 
sure that the rest of the staff remembers their contributions. 
 
A summary of the plan for action that includes the Change Step, Recommended Actions, 
Goal (s), Specific Actions, and Measures is presented in Table 8. 
 
Dissemination of Dissertation Findings 
Besides directly promoting organizational and policy changes, findings from this 
dissertation will be widely disseminated to encourage further studies and evaluations that may 
promote organizational and policy changes at the national level. Finding will be presented at key 
conferences and meetings (e.g., American Public Health Association (APHA), United States 
Conference on AIDS (USCA), International AIDS Conference, International Conference on HIV 
Treatment and Prevention Adherence, etc.) coupled with the submission of papers to leading 
peer reviewed journals for publication in journals such as the American Journal of Public Health, 
AIDS Care, AIDS Health and Behavior, and the Journal of the Association of Nurses in AIDS 
Care.  
 
Findings will also be presented to the HRSA HIV/AIDS Bureau staff that oversees the 
use of Ryan White funds across clinics in the United States and to the staff of the Centers for 
Disease Control and Prevention that are working in collaboration with State Health Departments 
to improve outcomes along each step of the HIV care continuum (diagnosis, retention in medical 
care, antiretroviral therapy, and viral suppression). Although findings from a small study like this 
might not produce organizational and policy changes across clinics in the United States, it will 
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promote further research that may lead to nationwide changes in how internalized HIV stigma is 
addressed to improve retention in HIV care among HIV- infected individuals. 
 
Table 8. Summary of Plan for Change  
Change Step Recommended 
Actions 
Goal (s) Specific Actions Measures 
1. Establishing 
a sense of 
urgency 
 Identify 
audiences 
 Frame 
messaging to 
reflect 
urgency of 
the situation 
 Develop 
open 
discussion 
among all 
Stakeholders  
 Refine Plan 
for Change 
 Present 
findings to 
staff at 
UM/JHM 
Clinics 
 Meet with 
UM/JHM 
leadership  
 Presentations 
conducted 
where study 
findings have 
been 
disseminated 
 Actions taken 
by leadership of 
organization 
2. Creating a 
guiding 
coalition 
 Identify 
members of 
the guiding 
coalition 
 Have leaders 
among all 
major 
stakeholders 
that can 
advocate for 
change 
 Meet 
individually 
with selected 
leaders 
involved in 
HIV/AIDS 
prevention and 
care activities 
in Miami-
Dade County 
 Number of 
leaders 
participating in 
the guiding 
coalition 
3. Developing a 
clear shared 
vision 
 Work with 
members of 
the guiding 
coalition to 
refine vision 
 Have a 
unified 
vision that 
promotes the 
importance 
of reducing 
internalized 
HIV stigma 
and 
improving 
patient-
 Develop clear 
messaging the 
conveys the 
vision 
 Vision accepted 
by all 
stakeholders  
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provider 
partnerships 
4. 
Communicating 
the vision 
 Identify 
different 
venues  
where the 
vision can be 
shared with 
all the 
community 
 Have a wider 
dissemination 
of the vision  
 Present 
findings and 
plan for 
change  to 
UM/JMH staff 
 Present 
findings and 
plan for 
change to 
Miami-Dade 
County 
commission 
 Enlist help 
from experts  
to 
communicate 
health related 
information to 
the wider 
public  
 Number of 
presentations 
conducted to 
key audiences 
 Number of 
newspaper 
articles 
describing the 
vision 
5. Empower 
People to Act 
on the Vision 
 Identify 
areas in 
which 
members of 
the guiding 
coalition 
(and other 
identified by 
them) can 
take leading 
roles  
 Ensure that 
activities to 
promote 
change are 
widespread 
and buy-in 
occurs at 
different 
levels of the 
organization  
 Meet with 
members of 
the guiding 
coalition to 
identify areas 
in which they 
or other 
assigned by 
them can take 
leading roles 
 Number of 
members of the 
guiding 
coalition and 
others recruited 
by them that 
are actively 
promoting 
change 
6. Create short 
term wins 
 Identify 
areas where 
short term 
wins can be 
obtained 
 Motivate 
individuals 
to continue 
with the 
change 
activity and 
address 
 Meet with 
members of 
the guiding 
coalition to 
identify areas 
where short 
term wins can 
 Number of 
interventions  
implemented 
within 6 
months of the 
plan 
acceptance by 
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concerns 
from 
potential 
naysayers  
be obtained 
interventions 
that is low 
cost 
the UM/JHM 
leadership 
7. Consolidate 
& build on the 
gains 
 Assess 
processes 
and actions 
to determine 
what is/is 
not working 
and if there 
are ways to 
improve 
these 
processes/act
ions.  
 Identify gaps 
to achieve 
vision of 
activities  
that 
minimizes 
internalized 
HIV stigma, 
strengthens 
patient-
provider 
partnerships 
and  improve 
retention in 
care  
 To ensure 
that vision is 
fulfilled  
 Conduct a 
thorough 
process and 
outcome 
evaluation 
 Identify gaps 
not covered 
by the plan 
for change 
and include 
new activities 
interventions 
as part of the 
long term plan 
for change  
 Number of 
processes or 
activities that 
are 
meeting/failing 
expected 
outcomes 
 Number of 
actions 
implemented to 
improve and/or 
correct 
processes 
and/or 
activities 
 Number of 
gaps identified 
and addressed 
within 12 
months of 
initiation of 
plan for change  
8. 
Institutionalize 
the change 
 Disseminate 
widely the 
progress  
 Publicly 
recognize 
key 
members of 
the change 
coalition 
 To make the 
changes 
permanent 
they must 
become a 
core part of 
the 
organization 
 Identify 
venues where 
progress can 
be 
disseminated 
 Identify 
venues/events 
where 
members of 
 Number of 
venues where 
progress was 
promoted 
 Number of 
venues/events 
where 
members of the 
guiding 
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 Recruit new 
members of 
the guiding 
coalition 
(or the 
system) 
the guiding 
coalition can 
be recognized 
 Work with 
existing 
members of 
the guiding 
coalition to 
recruit new 
cadre of 
members 
coalition where 
recognized 
 Number of  
new members 
of the guiding 
coalition 
recruited 
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APPENDIX 1: BASELINE INTERVIEW 
 
[To be read aloud by interviewer]: I am going to ask you some questions that will help me to 
know more about you. There are no right or wrong answers and we do not prefer one response 
over another. Giving us honest answers to these questions will help us to help others like you 
who need care for HIV infection. 
 
DEMOGRAPHICS 
 
D1. What is your date of birth? __ __/ __ __/ __ __ __ __     [dob] 
                     MM / DD / YYYY 
 
D2. So you are how old?        [age] 
  
D3. Do you consider yourself to be male, female, or transgender? [CHECK ONLY ONE.] 
 [gender] 
Male .......................................................................................  
Female ...................................................................................  
Transgender ...........................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
D4. What is your marital status? [marital_status] 
Never married/single .............................................................  
Married ..................................................................................  
Divorced/Separated ...............................................................  
Widow/Widower ...................................................................  
Living with partner/significant other .....................................  
Other (Specify:________________________________) .....  
Refused to answer ................................................................. 77 
Don’t know ............................................................................ 88 
 
D5. How many children do you have?    if zero, skip to 
D6[children] 
 
D5a. What is the HIV serostatus of your child(ren)? [hiv_children] 
HIV negative .........................................................................  
HIV positive ..........................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
D6. Who do you live with right now? [CHECK ONLY ONE] [live_with] 
Single .....................................................................................  
Spouse ................................................................................... if yes, ask D6a 
Significant other/partner ........................................................ if yes, ask D6a 
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Parents ...................................................................................  
Other extended family ...........................................................  
Children .................................................................................  
Children and Partner Alone ...................................................  
Friends ...................................................................................  
Other (Specify:________________________________) .....  
Refused to answer ................................................................. 77 
Don’t know ............................................................................ 88 
 
D6a. What is the HIV serostatus of your [SAY RESPONSE TO D6]? [hiv_status_live] 
HIV negative .........................................................................  
HIV positive ..........................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
D7. Do you consider yourself to be Hispanic or Latino? [hispanic] 
No ..........................................................................................  
Yes .........................................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
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D7a. Which of the following best describes your ethnic background? [ethnic_bkgrnd] 
Spaniard, from Spain .............................................................  
Mexican .................................................................................  
Central American ..................................................................  
South American .....................................................................  4 
Puerto Rican .......................................................................... 5 
Cuban ..................................................................................... 6 
Dominican .............................................................................  7 
Other (Specify:________________________________) .....  
Refused to answer ................................................................. 77 
Don’t know ............................................................................ 88 
 
 
D8. How would you describe your race/ethnicity? [race_ethni] 
White/Non-Hispanic ..............................................................  
Hispanic .................................................................................  
Black or African American ...................................................  
American Indian/Alaska Native ............................................  
Native Hawaiian/Other Pacific Islander ................................  
Other (Specify:________________________________) .....  
Refused to answer ................................................................. 77 
Don’t know ............................................................................ 88 
 
  
D9. Do you think of yourself as: [READ CHOICES. CHECK ONLY ONE.] [sex_orient] 
Homosexual, gay, or lesbian .................................................  
Heterosexual or straight .........................................................  
Bisexual .................................................................................  
Other (Specify:____________________) .............................  
Refused to answer .................................................................  
 Don’t know ............................................................................  
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D10. How do you think you were infected with HIV? 
Homosexual sex .................................................................... [inf_w_hiv.1] 
Heterosexual sex .................................................................... [inf_w_hiv.2] 
Drug use/sharing needles ....................................................... [inf_w_hiv.3] 
Blood transfusion .................................................................. [inf_w_hiv.4] 
Multiple Risks (Specify                                       ) ................. [inf_w_hiv.5] 
Refused to answer .................................................................  
 Don’t know ............................................................................ 88 
 
D11. How many years of school have you completed? _______[yrs_sch] 
 
D12. What is the highest level of education you completed? [CHECK ONLY ONE 
RESPONSE. DON’T READ CHOICES.]  [lvl_of_sch] 
Never attended school ...........................................................  
Grades 1 through 8 ................................................................  
Grades 9 through 11 ..............................................................  
Grade 12 or GED ...................................................................  
Some college, associate’s degree, or technical degree ..........  
Bachelor’s degree ..................................................................  
Any post-graduate studies .....................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
D13. Are you currently employed? [employed] 
No ..........................................................................................  
Yes .........................................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
     
D14. Do you have a regular place where you stay? [place_to_stay] 
No ..........................................................................................  
Yes .........................................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
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D15. Where do you currently live? [CHECK ONLY ONE RESPONSE. DON’T READ 
CHOICES.] [curnt_res]  
 
Your own or partner’s household/apartment .........................   
Someone else’s household/apartment ...................................   
Street ......................................................................................   
Treatment facility/halfway house ..........................................   
Single room, rented room, motel, etc ....................................   
Homeless shelter ....................................................................  
Other 1 (Specify:____________) ..........................................   
Refused to answer ................................................................. 77 
Don’t know ............................................................................ 88 
 
D16. In the past 7 months, have you been homeless at any time?  By homeless, I mean you 
were living on the street, in a shelter, a Single Room Occupancy (SRO) hotel, temporarily 
staying with friends/family, or living in a car. [homeless_7months]  
No ..........................................................................................  
Yes .........................................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
D17. In the past 7 months, have you been arrested and put in jail, detention, or prison for 
longer than 24 hours? [jail_7months]   
No ..........................................................................................  
Yes .........................................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
D18. In the past 7 months, have you had any kind of health insurance or coverage? I am not 
referring to coverage for medicines only.  [insur_7months]  
No ..........................................................................................  Skip to D19 
Yes .........................................................................................  
Refused to answer .................................................................   
Don’t know ............................................................................  
Skip to D19 
84 
 
D18a. What are all the kinds of health insurance or coverage you have had in the past 7 
months? [CHECK ALL THAT APPLY. DON’T READ CHOICES.]    
Private health insurance or HMO ..........................................   
Medicaid ................................................................................   
Medicare ................................................................................   
Ryan White ............................................................................   
Tricare/Champus ...................................................................   
Veterans Administration coverage ........................................   
Other 1 (Specify:____________) ..........................................   
Refused to answer ................................................................. 77 
Don’t know ............................................................................ 88 
 
D19. Was there a time in the past 7 months when you had no insurance coverage? 
[no_insur_7months] 
No ..........................................................................................  
Yes .........................................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
 
D20. In the past 7 months, where did most of your money or financial support come from? 
[CHECK ONLY ONE RESPONSE. DON’T READ CHOICES.] [money_7months]  
Salary or wages .....................................................................  
Savings/investments ..............................................................  
Pension/retirement fund ........................................................  
Supplemental Security Income (SSI) or Social Security  
     Disability Insurance (SSDI) .............................................  
Public assistance (“welfare”) .................................................  
Spouse, partner or family ......................................................  
Friends ...................................................................................  
No income/financial support .................................................  
Other (Specify:________________________________) .....  
Refused to answer ................................................................. 77 
Don’t know ............................................................................ 88 
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D21.  What is your average monthly income? Remember, this information will be kept 
confidential.   __________________[month_income] 
 
D22.  Do you own your own car? [own_car] 
No ..........................................................................................  
Yes .........................................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
  
D23.  Do you have a working telephone? [either “land” or cellular] [telephone] 
No ..........................................................................................  
Yes .........................................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
 
 
HEALTH CARE HISTORY 
 
[INTERVIEWER: Read to participant] I am going to ask you some questions about your 
experiences with your health care, particularly as they relate to your HIV. I would like you to 
think back to the time when you first were tested for HIV.  
 
A1. When did you first test positive for HIV?   
  
 __ __/ __ __ __ __ 
          (M   M  /   Y     Y     Y    Y ) [Month: 77 = Refused to answer, 88= Don’t know;  
                                        Year: 7777 = Refused to answer, 8888 = Don’t know]  
 
Inconsistency check: A1 (date first tested positive for HIV) must match date given on 
screener interview.  
 
A2.   So when you tested positive for HIV, where were you tested? [CHECK ONLY ONE 
RESPONSE. DON’T READ CHOICES.]    
 Community health center/primary care clinic/health  
      department general medical clinic (public source) ...........  
 Hospital .................................................................................  
 Private physician/HMO/primary care clinic (private source)  
 HIV counseling and testing site .............................................  
 STD clinic ..............................................................................  
 AIDS/infectious disease clinic ..............................................  
  
 Mobile test site (health department van, needle  
      exchange, etc.) ..................................................................  
 Correctional facility (jail/prison) ...........................................  
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 Emergency room ...................................................................  
 Blood bank ............................................................................  
 Prenatal/obstetrics clinic ........................................................  
 Family planning clinic ...........................................................  
 Drug treatment clinic .............................................................  
 Military facility ......................................................................  
 Insurance clinic/employee clinic ...........................................  
 Other(Specify:___________________________________)   
 Refused to answer .................................................................  
 Don’t know ............................................................................  
 
A2a. What was the main reason you were tested? [CHECK ONLY ONE RESPONSE. DON’T 
READ CHOICES.] 
 Illness (pneumonia, weight loss, etc.) ...................................  
 I’m an IDU……. ...................................................................  
 I’m a MSM ............................................................................  
 I had high-risk sexual behavior .............................................  
 Sex partner is IDU or MSM ..................................................  
 Sex partner is HIV positive ...................................................  
 Sex partner was worried I might have HIV ...........................  
 Needle sharing partner is HIV positive .................................  
 Surgery (pre-op) ....................................................................  
 Needle stick follow-up/ occupational exposure ....................  
  
 Health department informed me of possible exposure to  
      HIV (partner notification) ................................................  
 Blood donor ...........................................................................  
  
 Offered as a screening test at a clinic (STD, family  
      planning clinic, etc.) .........................................................  
  
 Started new relationship/wanted to stop using condoms  
      with partner .......................................................................  
 Pregnancy/prenatal visit ........................................................  
 Routine check-up/physical exam ...........................................  
 I just wanted to know/was curious ........................................  
 Other (Specify_________________________________) ....  
 Refused to answer .................................................................  
 Don’t know ............................................................................  
 
A3. When did you first go to a health care provider for HIV care after learning you had HIV?  
  
 __ __/ __ __ __ __ 
          (M   M  /   Y     Y     Y    Y ) [Month: 77 = Refused to answer, 88= Don’t know;  
    Year: 7777 = Refused to answer, 8888 = Don’t know]  
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A4. When did you last go to a health care provider for HIV care?] 
           __ __/ __ __ __ __ [Month: 77 = Refused to answer, 88= Don’t know;  
 (M   M  /   Y     Y     Y    Y ) Year: 7777 = Refused to answer, 8888 = Don’t know] 
             
Interviewer instructions: If A4 (date last went to health care provider) is more than 6 
months prior to interview date, go to A5a; otherwise, skip to A6. 
  
A5a. What were the reasons you didn’t go to a health care provider for HIV care during the past 6 
months? [CHECK ALL THAT APPLY. DON’T READ CHOICES. MAY NEED TO 
PROMPT WITH “IS THERE ANY OTHER REASON?”] 
 Felt good, didn’t need to go ...................................................  
 Forgot to go ...........................................................................  
 Missed my appointment(s) ....................................................  
 Too busy to go .......................................................................  
 Moved or out of town ............................................................  
 Don’t want to think about being HIV positive ......................  
 Didn’t believe test result ........................................................  
 Unable to get transportation ..................................................  
 Unable to get childcare ..........................................................  9  
 Inconvenient (location, hours, time, etc.) ..............................  
 Didn’t know where to go .......................................................  
 Hard to find the right doctor or a good doctor for me ...........  
 CD4 count and viral load were good .....................................  
 Drinking or using drugs .........................................................  
 Living on the street ................................................................  
 Didn’t have money ................................................................  
 Didn’t have insurance ............................................................  
 Unable to get earlier appointment .........................................  
 Incarcerated ...........................................................................  
 Other 1 (Specify:_________________________) ................  
 Other 2 (Specify:_________________________) ................  
 Other 3 (Specify:_________________________) ................    
 Other 4 (Specify:_________________________) ................  
 Refused to answer .................................................................  
 Don’t know ............................................................................  
A5b. What was the main reason you didn’t go to a health care provider for HIV care during the 
past 6 months? I am going to read a list of the reasons you just gave me.  Please tell me 
which of these was your main reason.  [CHECK ONLY ONE RESPONSE. READ 
RESPONSES GIVEN in A7a.] 
 Felt good, didn’t need to go ...................................................  
 Forgot to go ........................................................................... [RNOCRL2] 
 Missed my appointment(s) .................................................... [RNOCRL3] 
 Too busy to go ....................................................................... [RNOCRL4] 
 Moved or out of town ............................................................ [RNOCRL5] 
 Don’t want to think about being HIV positive ...................... [RNOCRL6] 
 Didn’t believe test result ........................................................ [RNOCRL7] 
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 Unable to get transportation .................................................. [RNOCRL8] 
 Unable to get childcare .......................................................... [RNOCRL9] 
 Inconvenient (location, hours, time, etc.) .............................. [RNOCRL10] 
 Didn’t know where to go ....................................................... [RNOCRL11] 
 Hard to find the right doctor or a good doctor for me ........... [RNOCRL12] 
 CD4 count and viral load were good ..................................... [RNOCRL13] 
 Drinking or using drugs ......................................................... [RNOCRL14] 
 Living on the street ................................................................ [RNOCRL15] 
 Didn’t have money ................................................................ [RNOCRL16] 
 Didn’t have insurance ............................................................ [RNOCRL17] 
 Unable to get earlier appointment ......................................... [RNOCRL18] 
 Incarcerated ........................................................................... [RNOCRL19] 
 Other 1 (Specify:_________________________) ................ [RNOCRL20] 
 Other 2 (Specify:_________________________) ................ [RNOCRL21] 
 Other 3 (Specify:_________________________) ................ [RNOCRL22] 
 Other 4 (Specify:_________________________) ................ [RNOCRL23] 
 Refused to answer .................................................................  
 Don’t know ............................................................................  
 
A6. Has a doctor or health care provider ever told you that you had AIDS?  [DRAIDS] 
No ..........................................................................................   
Yes .........................................................................................  
Refused to answer .................................................................   
Don’t know ............................................................................  
 
SAY: “Now, I’m going to ask you some questions about your CD4 counts, also called T 
cell counts.” 
 
A7. Have you ever had a lab test called a T-cell or CD4 count? [CD4_DONE] 
No ..........................................................................................   
Yes .........................................................................................  
Refused to answer .................................................................   
Don’t know ............................................................................  
 
A7a. When was your last T-cell (CD4) count given to you?  [LASTCD4] 
 
           __ __/ __ __ __ __ [Month: 77 = Refused to answer, 88= Don’t know;  
 (M   M  /   Y     Y     Y    Y ) Year: 7777 = Refused to answer, 8888 = Don’t know] 
             
A7b.  What was your last T-cell (or CD4) count? 
[USE RESPONSE CARD A.]  [CDLWST] 
0-49 ........................................................................................  
50-99 ......................................................................................  
100-199 ..................................................................................  
200-349 ..................................................................................  
Skip to Say 
 box before A9 
Skip to Say box 
before A9 
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350-499 ..................................................................................  
500 or more ...........................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  8 
 
SAY: “Now I’m going to ask you some questions about your viral load tests.” 
 
A8. Have you ever had a viral load test (to measure the amount of HIV in your blood)? 
[VL_DONE] 
 No .........................................................................................   
Yes .........................................................................................  
Refused to answer .................................................................   
Don’t know ............................................................................  
 
A8a. When was your last HIV viral load count given to you?  [LASTVL] 
           
 __ __/ __ __ __ __ 
          (M   M  /   Y     Y     Y    Y ) [Month: 77 = Refused to answer, 88= Don’t know;  
    Year: 7777 = Refused to answer, 8888 = Don’t know]  
 
A8b. What was your last viral load count? 
[USE RESPONSE CARD B.]   
Below the level of detection, undetectable ............................  
Detectable but less than 5,000 viral copies/ml ......................  
5,000 to 100,000 viral copies/ml ...........................................  
Greater than 100,000 viral copies/ml ....................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
 
USUAL SOURCE OF HIV CARE 
 
SAY: “Now I’m going to ask you some questions about the places where you get medical care 
for HIV.  If you don’t remember everything, that’s okay.  Tell me what you remember.” 
 
A9.     In the past 7 months, is there one place in particular, like a doctor’s office or clinic   
 where you usually go for most of your HIV care? HIV care may include T-cell tests, viral 
load tests, or prescriptions for HIV medicines?  [PLCARE] 
 No ..........................................................................................     
 Yes .........................................................................................  
 Refused to answer .................................................................                
        Don’t know ............................................................................                
 
A10.  What is the name of this place?  Remember, this information will be kept confidential.          
Jackson Memorial SI Clinic ..............................................................  
 
Skip to A14 
Ask A.11, then skip to A14 
Skip to next 
section, 
Usual care 
Skip to next 
section, 
Usual care 
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Jackson Memorial OB/Gyn clinic .....................................................  
PHT/North Dade Health Center ........................................................  
P.E.T. Center .....................................................................................  
Other 1 (Specify:____________________________________) ......  
 Refused to answer .............................................................................  
Don’t know ........................................................................................  
 
A10a.  Did you get any sort of care at [USE FACILITY NAME IN A12] between [USE 
TODAY’S DATE] and [USE TODAY’S DATE AND 7 MONTHS EARLIER]?   
[CAREPER1] 
 No ..........................................................................................                           
 Yes .........................................................................................           
 Refused to answer .................................................................                 
            Don’t know ............................................................................                
       
A10b.  Between [USE TODAY’S DATE] and [USE TODAY’S DATE AND 7 MONTHS 
EARLIER], how many times did you go to [USE FACILITY NAME IN A12] for 
any sort of care? [TIMECAR] 
 
 ___ ___ ___   [777 = Refused to answer, 888 = Don’t know]  
 
A10c.  Is your HIV provider the same race/ethnicity as you?  
 No ..........................................................................................                           
 Yes .........................................................................................           
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A10d.  How long (in minutes) does it take you to arrive at the HIV clinic from where you stay? 
 ___ ___ ___   [777 = Refused to answer, 888 = Don’t know]  
 
A11.    In the past 7 months, have you been to any other doctor’s office or clinic for your HIV 
care?  If you were in jail or prison this includes any visits with doctors or nurses while 
you were there.   [OHEPRO] 
 No ..........................................................................................                 
 Yes .........................................................................................  
 Refused to answer .................................................................                           
  Don’t know ............................................................................                
 
 
A11a.  What is the name of this place?            
 
A11b.  Between [USE TODAY’S DATE] and [USE TODAY’S DATE AND 7 MONTHS 
EARLIER], how many times had you been to [USE FACILITY NAME FROM A11a] for 
any sort of care? [TIMECAR] 
 ___ ___ ___   [777 = Refused to answer, 888 = Don’t know]  
 
A12. During the past 7 months, how many times did you go to an emergency room for  
 care? (This would be visits made to the ER for care that did not lead to a hospital 
admission. Please don’t include visits related to injuries such as accidents or other types 
of injuries.)  [ERVIS] 
  ___ ___        [77=Refused to answer, 88=Don’t know] 
 
A12a. What for?   
____________________________________________________________________ 
 
A13.  During the past 7 months, how many times did you go to an urgent care center for care? 
(This would    
be visits made to the urgent care center that did not lead to a hospital admission. Please 
don’t include  
visits related to injuries such as accidents or other types of injuries.)  [URCARVIS] 
  ___ ___        [77=Refused to answer, 88=Don’t know] 
 
A13a. What for?   
____________________________________________________________________ 
 
A14.    During the past 7 months, how many times were you admitted to a hospital?  (Please 
don’t include  
 visits that were made only to the emergency room.)                
 [IF ZERO, SKIP TO A17]   [HOSP] 
___ ___        [77=Refused to answer, 88=Don’t know]  
 
A14a. What for?   
____________________________________________________________________ 
Skip to A14 
Skip to A14  
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A15. During the past 7 months, how many days total did you spend in a hospital?     
 ___ ___              [77=Refused to answer, 88=Don’t know] 
 
 
 
A16. During the past 7 months, were you admitted to a mental health facility?    
 No ..........................................................................................                 
 Yes .........................................................................................           
 Refused to answer .................................................................                
            Don’t know ............................................................................ 8              
 
A17. How many times have you been treated for any psychological or emotional problems? 
A17a. In a hospital     _____________ 
A17b. As an Outpatient or Private patient     ________________ 
 
A18. Do you receive a pension for a psychiatric disability? 
 0 - No  
 1 – Yes 
 
A19. Have you had a significant period, (that was not a direct result of drug/alcohol use), in 
which you have: 
(Code: 0 – No, 1 – Yes for each of the following.) 
  PAST 30 
DAYS 
IN YOUR 
LIFE 
A19a. Experienced serious depression   
A19b. Experienced serious anxiety or tension   
A19c Experienced hallucinations   
A19d. Experienced trouble understanding, concentrating or 
remembering 
  
A19e. Experienced trouble controlling violent behavior   
A19f. Experienced serious thoughts of suicide   
A19g. Attempted suicide   
A19h. Been prescribed medication for any psychological 
emotional problem 
  
 
A20. How many days in the past 30 have you experienced these psychological or emotional 
problems?  _____________________________ 
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A21. How much have you been troubled or bothered by these psychological or emotional 
problems in the past 30 days? 
 Not at all ................................................................................  
 Slightly ..................................................................................  
 Moderately .............................................................................  
 Considerably ..........................................................................  
 Extremely ..............................................................................  
 Refused to answer .................................................................  
  Don’t know ............................................................................  
 
A21. How important to you now is treatment for these psychological problems? 
 Not at all ................................................................................  
 Slightly ..................................................................................  
 Moderately .............................................................................  
 Considerably ..........................................................................  
 Extremely ..............................................................................  
 Refused to answer .................................................................  
  Don’t know ............................................................................  
 
A22.   During the past 7 months, were you admitted to an inpatient drug or alcohol treatment 
facility?   [ADDRAL] 
 No ..........................................................................................                 
 Yes .........................................................................................           
 Refused to answer .................................................................                
 Don’t know ............................................................................                
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ANTIRETROVIRAL TREATMENT 
 
SAY: “Next I would like to ask you some questions about medicines you may take to treat HIV 
infection. 
 
A23.     Have you ever taken any antiretroviral medicines to treat your HIV?  These medicines are 
also known as ART, HAART, or the AIDS cocktail. Other pills to treat infections, such as 
Bactrim, are not antiretroviral medicines. [ANTIRET] 
 No………………….…………………..…… .......................              Skip to A26 
 Yes………………………………………..…… ...................                        
 Refused to answer…………………………… .....................                                    
        Don’t know….......... ..............................................................                         
 
 
A24. Are you currently taking antiretroviral therapy (HIV medications)?   
No ..........................................................................................   
Yes .........................................................................................  
Refused to answer .................................................................   
Don’t know ............................................................................  
 
A24a. How long have you been taking your current regimen? (record responses in months)  
   
 
A25. What are the main ways your prescription medicines for HIV and related illnesses were paid 
for in the past 7 months? [CHECK ALL THAT APPLY. DON’T READ CHOICES.]   
Private health care coverage ..................................................  
I got my HIV medicines at a public clinic .............................  
I paid for my HIV medicines myself (“out of pocket”) ........  
AIDS Drug Assistance Program (ADAP) .............................  
I participated in a clinical research trial or drug study that  
     provided my medicines ....................................................  
An AIDS service organization provided me my medicines ..  
Medicaid/Medicare ................................................................ 7   
Other 1 (Specify: _____________________________) ....... 8   
Refused to answer ................................................................. 77 
Don’t know ............................................................................ 88 
ONLY ASK THE FOLLOWING QUESTIONS IF PERSON HAS NEVER TAKEN 
ANTIRETROVIRAL MEDICATIONS 
 
A26. What are the reasons you have never taken any antiretroviral medicines? 
 [CHECK ALL THAT APPLY. DON’T READ CHOICES.]  
 Doctor advised to delay treatment .........................................  1  
 Participant believed he/she didn't need medications because  
Skip to A27 
 
Skip to A27 
Skip to A26 
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    felt healthy or believed HIV laboratory results were good ..  
 Due to side Associations of medication ................................  
 Felt depressed or overwhelmed .............................................  
 Didn’t want to think about being HIV positive .....................  
 Worried about ability to adhere .............................................  
 Drinking or using drugs .........................................................  
 Money or insurance issues ....................................................  
 Homeless ...............................................................................  
 Taking alternative or complementary medicines .................. [ 
 Other 1 (Specify:______________________________) ......   
Refused to answer .................................................................  
 Don’t know ............................................................................ 88 
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A26a. What is the main reason you have never taken any antiretroviral medicines?  I am 
going to read a list of the reasons you just gave me.  Please tell me which of these was 
your main reason.  [CHECK ONLY ONE RESPONSE. READ RESPONSES GIVEN 
IN A26.] [MNANT8] 
 
 Doctor advised to delay treatment .........................................  
Participant believed he/she didn't need medications because  
    felt healthy or believed HIV laboratory results were good ...  
 Due to side Associations of medication ................................   
 Felt depressed or overwhelmed .............................................  
 Didn’t want to think about being HIV positive .....................  
 Worried about ability to adhere .............................................  
 Drinking or using drugs .........................................................  
 Money or insurance issues ....................................................  
 Homeless ...............................................................................  
 Taking alternative or complementary medicines ..................  
 Other 1 (Specify:______________________________) ...... [SMNANT81]  
Refused to answer .................................................................  
 Don’t know ............................................................................  
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ONLY ASK THE FOLLOWING QUESTIONS IF PERSON IS NOT CURRENTLY 
TAKING ANTIRETROVIRAL MEDICATIONS 
 
A27.  What are the reasons you aren’t currently taking any antiretroviral medicines? 
 [CHECK ALL THAT APPLY. DON’T READ CHOICES.]   
 Doctor advised to delay or stop treatment .............................  [NANT8CA] 
 Participant believed he/she didn't need medications because  
    felt healthy or believed HIV laboratory results were good ...  [NANT8CB] 
 Due to side Associations of medications ...............................  [NANT8CC] 
 Felt depressed or overwhelmed .............................................  [NANT8CD] 
 Didn’t want to think about being HIV positive .....................  [NANT8CE]                                                                                                                                    
 Worried about ability to adhere .............................................  [NANT8CF] 
 Drinking or using drugs .........................................................  [NANT8CG] 
 Money or insurance issues ....................................................  [NANT8CH] 
 Homeless ...............................................................................  [NANT8CI] 
 Taking alternative or complementary medicines ..................  [NANT8CJ] 
 Other 1 (Specify:_____________________________) ........  [NANT8CK]  
Refused to answer .................................................................  
 Don’t know ............................................................................  
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A27a.   What is the main reason you aren’t currently taking any antiretroviral medicines? 
I am going to read a list of the reasons you just gave me.  Please tell me which of these 
was your main reason.  [CHECK ONLY ONE RESPONSE. READ  RESPONSES GIVEN 
IN A27.]  [MNANT8C] 
 Doctor advised to delay or stop treatment .............................   
Participant believed he/she didn't need medications because  
   felt healthy or believed HIV laboratory results were good   
 Due to side Associations of medications ...............................   
 Felt depressed or overwhelmed .............................................   
 Didn’t want to think about being HIV positive .....................   
 Worried about ability to adhere .............................................   
 Drinking or using drugs .........................................................   
 Money or insurance issues ....................................................   
 Homeless ...............................................................................   
 Taking alternative or complementary medicines ..................   
Other 1 (Specify:_____________________________) ........ [SMNAN8C1] 
 Refused to answer .................................................................  
 Don’t know ............................................................................  
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UNMET NEEDS 
SAY:  “Now I am going to ask you some questions about your need for services related to 
HIV.” 
 
In the past 7 months, have you needed any of these services: [SHOW RESPONSE CARD D.] 
 
Interviewer instructions: If response to N1a is “No,” “Refused to answer,” or “Don’t 
know”, skip to N2a; otherwise, go to N1b.  If response to N1b is “Yes,” “Refused to 
answer,” or “Don’t know,” skip to N2a; otherwise, go to N1c. Follow the same pattern for 
N1-N14.  
 
  [Needed this 
service in the 
past 7 
months?] 
If “Yes” in 
N1a-N14a, 
ask:  
Have you been 
able to get this 
service in the 
past 7 
months? 
If “No” in 
N1b-N14b, 
ask: 
What was the 
main reason 
you haven’t 
been able to 
get this 
service? 
  CODE: 
No = 0,  
Yes = 1, 
Refused to 
answer = 7,  
Don’t know = 8 
CODE: 
No = 0, 
Yes = 1, 
Refused to 
answer = 7,  
Don’t know = 
8 
CODE: 
SEE CODE 
LIST BELOW 
FOR 
RESPONSES. 
[CHECK 
ONLY ONE. 
DON’T READ 
CHOICES.]  
 
N1. HIV case management services  
[HIVCMS][HIVCMS12][HIVCMSRS] 
a.    [______] b.    [______] c.    [______] 
N2. Mental health counseling 
[MENCON][MENCON12][MENCONRS] 
a.    [______] b.    [______] c.    [______] 
N3.  Social services, such as insurance assistance or 
financial counseling 
[SOCSER][SOCSER12][SOCSERRS] 
a.    [______] 
 
b.    [______] 
 
c.    [______] 
N4. Assistance in finding a doctor for ongoing 
medical services 
[DOCASS][ASSDOC12][ASSDOCRS] 
a.    [______] b.    [______] c.    [______] 
N5. Assistance in finding dental services 
[DENSER][DENSER12][DENSERRS] 
a.    [______] b.    [______] c.    [______] 
N6. 
 
Adherence support services – Help managing 
medications 
[ASS][ASS12][ASSRS] 
a.    [______] b.    [______] c.    [______] 
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  [Needed this 
service in the 
past 7 
months?] 
If “Yes” in 
N1a-N14a, 
ask:  
Have you been 
able to get this 
service in the 
past 7 
months? 
If “No” in 
N1b-N14b, 
ask: 
What was the 
main reason 
you haven’t 
been able to 
get this 
service? 
  CODE: 
No = 0,  
Yes = 1, 
Refused to 
answer = 7,  
Don’t know = 8 
CODE: 
No = 0, 
Yes = 1, 
Refused to 
answer = 7,  
Don’t know = 
8 
CODE: 
SEE CODE 
LIST BELOW 
FOR 
RESPONSES. 
[CHECK 
ONLY ONE. 
DON’T READ 
CHOICES.]  
 
N7. Home health services, such as home nursing 
care or assistance 
[HHSASS][HHSASS12][HHSSERRS] 
a.    [______] b.    [______] c.    [______] 
 
N8. Chore or homemaker services (paid or 
volunteer)   
[HOMSER][HOMSER12][HOMSERRS] 
a.    [______] b.    [______] c.    [______] 
 
N9. Assistance in finding shelter or housing 
[SHLTER][SHLTER12][SHLTRRS] 
 
a.    [______] 
 
b.    [______] 
 
c.    [______] 
 
N10. Assistance with finding meals or food 
[MLSFOD][MLSFOD12][MLSFODRS] 
a.    [______] b.    [______] c.    [______] 
 
N11. Transportation assistance 
[TRSASS][TRSASS12][TRSSERRS] 
a.    [______] b.    [______] c.    [______] 
 
N12. Childcare services 
[CHLDCR][CHLDCR12][CHDCARRS] 
a.    [______] b.    [______] c.    [______] 
 
N13. Education or information on HIV risk reduction 
[HIVEDU][HIVEDU12][HIVEDURS] 
 
a.    [______] 
 
b.    [______] 
 
c.    [______] 
N14. Other (Specify:___________________) 
[OTHSERNM][OTHSER12][OTHSERRS] 
a.    [______] b.    [______] c.    [______] 
Interviewer instructions: For N1c-N14c: [ENTER ONLY ONE RESPONSE. DON’T READ 
CHOICES.] 
 
1 I don’t know where to go or who to call 8 Transportation problems 
2 Didn’t complete application process  9 Language barrier 
3 The system is too confusing    10 Not eligible / denied services 
4 The waiting list is too long   11 I’m too sick to get out 
5 It isn’t available in my area    12 Other (Specify: ________________) 
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6 They charge too much     77 Refused to answer 
7 I don’t have the money to pay   88 Don’t know 
DRUG AND ALCOHOL USE HISTORY 
INJECTION DRUG USE 
 
SAY: “The next questions are about drug and alcohol use.  Please remember your answers will be 
kept confidential and that you can refuse to answer any question you are not comfortable with.  
First I’m going to ask you about injection drug use.  This means injecting drugs yourself and/or 
having someone who isn't a health care provider inject you.” 
 
U1.  Have you ever shot up or injected any drugs that weren’t prescribed for you?  By shooting 
up, I mean anytime you might have used drugs with a needle, either by mainlining, skin 
popping or muscling.   [EVERINJ] 
No ..........................................................................................   
Yes .........................................................................................  
Refused to answer .................................................................   
Don’t know ............................................................................  
 
U2.  When was the last time you shot up or injected any drugs (that weren’t used for medical 
purposes)?   [LASTINJ] 
  
 __ __/ __ __ __ __ 
          (M   M  /   Y     Y     Y    Y ) [Month: 77 = Refused to answer, 88= Don’t know;  
    Year: 7777 = Refused to answer, 8888 = Don’t know]  
 
Interviewer instructions: If date in U2 is greater than 7 months from the interview date, 
skip to Say box before U8; otherwise, go to Say box before U3. 
  
 Skip to Say box 
before U8 
 Skip to Say box 
before U8 
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SAY:   I'm going to read you a list of drugs.  For each drug I mention, please tell me how often you 
injected it in the past 7 months.” 
 
U3. How often did you inject:   [CHECK ONLY ONE RESPONSE PER TYPE OF DRUG. USE 
RESPONSE CARD E. READ EACH DRUG CHOICE.]    
  
    More  More  More  Less   
    than  than  than  than    
   Didn't once  Once  once a Once a  once a Once a 
 once a  Ref      Don’t 
   use a day a day week week month month month       
Know  
a. Heroin and cocaine  
     ...  ......  ......  ......  ......  ...........  ......  ......  ....  
[HERCOC] 
b. Heroin alone  ...  ......  ......  ......  ......  ...........  ......  ......  ....  
[HEROIN] 
c. Cocaine alone………  ...  ......  ......  ......  ......  ...........  ......  ......  ....  
[COCAINE] 
 ...  ......  ......  ......  ......  ...........  ......  ......  ....  
[CRACK] 
e. Methamphetamines  
 (crystal, meth, tina, 
    crank, ice)  ...  ......  ......  ......  ......  ...........  ......  ......  ....  
[CRAMTCI] 
 ..  ......  ......  ......  ......  ...........  ......  ......  ....  
[AMPHETA] 
 ...  ......  ......  ......  ......  ...........  ......  ......  ....  
[OXYCON] 
 ...  ......  ......  ......  ......  ...........  ......  ......  ....  
[STRHRM] 
 ...  ......  ......  ......  ......  ...........  ......  ......  ....  
[OINJDRY] 
   (Specify: _______________________________________)  [OINJDR] 
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NON-INJECTION DRUG USE 
 
SAY: “Now I’m going to ask you about alcohol and drugs that you may have used but did not 
inject. I will refer to these as non-injection drugs.  This includes drugs like marijuana, crystal, 
cocaine, crack, club drugs, painkillers, or poppers.  Again, we are interested in drugs that were no 
prescribed for you.” 
 
U4. In the past 7 months, have you used alcohol or any non-injection drugs?   [ANID12] 
No ..........................................................................................   
Yes .........................................................................................  
Refused to answer .................................................................   
Don’t know ............................................................................  
 
SAY: The next few questions ask about the past 30 days, rather than the past 7 months. 
 
U5. During the past 30 days, on how many days did you have a drink containing alcohol? 
  [DRINK] 
  ___ ___     [Refused to answer = 77, Don’t know = 88] 
 
Inconsistency check: U5 (number of days the respondent had an alcoholic drink during the past 
30 days) cannot be greater than 30.  
 
Interviewer instructions: If U5 is “0,” “Refused to answer,” “Don’t know,” skip to Say box 
before U9. 
 
U6. During the past 30 days, how many drinks did you have on a typical day when you were 
drinking?  By a drink I mean a can of beer, a glass of wine or a shot of hard liquor.  [NDRINK] 
   
  ___ ___   [Refused to answer = 77, Don’t know = 88] 
 
Inconsistency check: U6 (number of drinks on a typical day during the past 30 days) cannot 
greater than 30.  
 
Interviewer instructions: If DEMOGRAPHICS D3 (gender) is “Female” skip to U8. 
 
U7. On how many days in the past 30 days did you have 5 or more drinks?   [DRINK5] 
    ___ ___    [Refused to answer = 77, Don’t know = 88]  
 
Inconsistency check: U7 (number of days the respondent had 5 or more drinks during the 
past 30 days) cannot be greater than 30.  
 
Interviewer instructions: After recording response, skip to Say box before U9. 
Skip to Say box 
before U5 
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U8. On how many days in the past 30 days did you have 4 or more drinks?  [DRINK4] 
  
    ___ ___     [Refused to answer = 77, Don’t know = 88]  
 
Inconsistency check: U8 (number of days the respondent had 4 or more drinks during the 
past 30 days) cannot be greater than 30.  
 
SAY: “I'm going to read you a list of drugs, including alcohol.  For each one I mention, 
please tell me how often you used it in the past 7 months.  Don’t include drugs you 
injected or drugs that were used for medical purposes.” 
 
U9.  How often did you use:  [CHECK ONLY ONE RESPONSE PER TYPE OF DRUG. USE 
RESPONSE CARD E. READ EACH DRUG CHOICE.] 
    More  More  More  Less   
    than  than  than  than    
   Didn't once  Once  once a Once a  once a Once a 
 once a  Ref      Don’t 
   use a day a day week week month month month       
Know  
 
 ....  ......  ......  ......  ...........  ......  ......  ...... 
  
[ALCOHOL] 
Inconsistency check: U9 cannot be “didn’t use alcohol” if U5 is 
“1” or greater than 1.  
b. Methamphetamines (crystal,  
 ..  ......  ......  ......  ...........  ......  ......  ....  
[CRYMTCI] 
c.  Othe  ........  ......  ......  ...........  ......  ......  ...... 
  
[AMPHETA1] 
 .........  ......  ......  ...........  ......  ......  ...... 
  
[CRACK1] 
e. Cocaine that is smoked 
      .......  ......  ......  ...........  ......  ......  ...... 
  
[COCSMO] 
f. Downers such as Valium,  
    Ativan, or  ..........  ......  ......  ...........  ......  ......  ...... 
  
[DOWNERS] 
g. Painkillers such as Oxycontin,  
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     ..........  ......  ......  ...........  ......  ......  ...... 
  
[PAINKILL] 
h. Hallucinogens such as LSD  
     ..........  ......  ......  ...........  ......  ...... 
  ....  
[HALLUC] 
 
 ..........  ......  ......  ...........  ......  ......  ...... 
  
[XECT] 
    More  More  More  Less   
    than  than  than  than    
   Didn't once  Once  once a Once a  once a Once a 
 once a  Ref      Don’t 
   use a day a day week week month month month       
Know  
 
 .........  ......  ......  ...........  ......  ......  ...... 
  
[SPECK] 
k. GHB………………………   ..........  ......  ......  ...........  ......  ......  ...... 
  
[GHB] 
l. Heroin/opium that is 
   smoked or snorted…….. ....  ......  ......  ......  ...........  ......  ......  ...... 
  
[HEROINS] 
m. Marijuana………………..    ..........  ......  ......  ...........  ......  ......  ...... 
  
[MARIJU] 
n. Poppers ( amyl nitrate)  ..........  ......  ......  ...........  ......  ......  ...... 
  
[POPPERS] 
o. Steroids/Hormones  ..........  ......  ......  ...........  ......  ......  ...... 
  
[STRHORMS] 
 
U9p.  Did you use any other non-injection drugs that I haven’t asked about?  [ONINJDY] 
 
No ..........................................................................................  
Yes .........................................................................................  
Refused to answer .................................................................  
Don’t know ............................................................................  
 
U9q.  What other drug did you use?  (Specify: _________________________) [ONINJDR] 
106 
 
 
U9r.  How often did you use ___________________________ [RESPONSE TO U9q]?   
  
    More  More  More  Less   
    than  than  than  than    
   Didn't once  Once  once a Once a  once a Once a 
 once a  Ref      Don’t 
   use a day a day week week month month month       
Know  
 ......  ......  ......  ......  ...........  ......  ......  ...... 
  
[ONINJDRH]  
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DISCLOSURE 
 
[Interviewer read to participant:] We are trying to understand which people you are close 
to, and to figure out who does and does not know about your HIV infection.  I am going to 
ask you about certain people in your life to whom you may have told about your HIV 
infection.  
 
 
DSC1.  Have you told your spouse/significant other that you 
have HIV? [t#.dsc1] 
□0No * □1Yes  □9N/A 
DSC2.  Have you told your mother that you have HIV? [t#.dsc2] □0No * □1Yes  □9N/A 
DSC3.  Have you told your father that you have HIV? [t#.dsc3] □0No * □1Yes  □9N/A 
DSC4.  Have you told any of your other family members that 
you have HIV? [t#.dsc4] 
□0No * □1Yes  □9N/A 
 
 
 
 
How many of … ___________ … have you told that you have HIV? 
 
  None Some All N/A 
DSC5. …Your children…[t#.dsc5] □0 □1 □2 □9 
DSC6. …Your brothers…[t#.dsc6] □0 □1 □2 □9 
DSC7. …Your sisters…[t#.dsc7] □0 □1 □2 □9 
DSC8. …Your other family 
members…[t#.dsc8] 
□0 □1 □2 □9 
DSC9. …Your friends…[t#.dsc9] □0 □1 □2 □9 
DSC10. …Your colleagues / the people 
you work with…[t#.dsc10] 
□0 □1 □2 □9 
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Attitudes Toward Health Care Providers Scale 
 
[Interviewer: read aloud to participant] I am going to read some statements to you and then 
ask to tell me how strongly you agree (a score or 6) or disagree (a score of 1) that best 
describes how you feel about it. Medical team includes the doctor, nurses, dietician, social 
worker and any other medical staff member you interact with at the clinic. 
 
1. I believe that my medical team is knowledgeable about HIV/AIDS. [t#.athcps_1] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
2. My medical team puts an effort into my treatment. [t#.athcps_2] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
3. I believe my medical team is motivated to help me. [t#.athcps_3] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
4. My medical team cares about my health. [t#.athcps_4] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
5. I believe my medical team knows a lot about HIV drugs. [t#.athcps_5] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
6. I believe I receive the best available health care. [t#.athcps_6] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
7. My medical team is lazy. [t#.athcps_7] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
8. My medical team is knowledgeable about new HIV treatments. [t#.athcps_8] 
Strongly 
Disagree 
    Strongly Agree 
1 2 3 4 5 6 
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9. I believe that my medical team cares about me. [t#.athcps_9] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
10.  My medical team supports me. [t#.athcps_10] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
11. My medical team encourages me. [t#.athcps_12] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
12.  My medical team is helpful. [t#.athcps_12] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
13. My medical team makes me feel comfortable. [t#.athcps_13] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
14.  The medical team spends enough time with me. [t#.athcps_14] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
15.  My medical team is sensitive to how I feel. [t#.athcps_15] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
16. My medical team thinks I am a bad person because I have HIV. [t#.athcps_16] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
17.  My medical team cares about my opinion. [t#.athcps_17] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
18. I believe that my medical team sees me as stupid. [t#.athcps_18] 
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Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
 
19. My medical team judges me. [t#.athcps_19] 
Strongly 
Disagree 
    
Strongly 
Agree 
1 2 3 4 5 6 
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ENGAGEMENT WITH HEALTHCARE PROVIDER SCALE 
 
[Interviewer: Read aloud to participant] The next questions I will ask you are about your 
relationship with your HIV doctor. Please tell me on a scale from 1 to 4, with 1 = always, 
2=usually, 3=sometimes, & 4=never, how well each of these statements fit how you feel about 
your relationship with your HIV doctor. 
 
My doctor… 
 
 Always usually sometimes never 
a.  Listens to me [t#.ehps_a] 1 2 3 4 
b.  Cares about me [t#.ehps_b] 1 2 3 4 
c.  Answers my questions [t#.ehps_c] 1 2 3 4 
d.  Spends enough time with me 
[t#.ehps_d] 
1 2 3 4 
e.  Involves me in decisions 
[t#.ehps_e] 
1 2 3 4 
f.  Respects my choices [t#.ehps_f] 1 2 3 4 
g.  Deals with my problems 
[t#.ehps_g] 
1 2 3 4 
h.  Engages me in my care [t#.ehps_h] 1 2 3 4 
i.  Is helpful to me [t#.ehps_i] 1 2 3 4 
j.  Respects me [t#.ehps_j] 1 2 3 4 
k.  Supports my decisions [t#.ehps_k] 1 2 3 4 
l.  Sees me when I ask [t#.ehps_l] 1 2 3 4 
m.  Provides me with information 
[t#.ehps_m] 
1 2 3 4 
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HIV Stigma Scale 
 
Instructions: We are interested in how you feel about the following statements. Read each statement 
carefully. Indicate how you feel about each statement. Circle one number on each line. 
 
  Not at All  Rarely  Sometimes  Often 
1 
I felt blamed by others for my 
illness. 
1 2 3 4 
2 I felt ashamed of my illness. 1 2 3 4 
3 
I thought my illness was a 
punishment for things I’ve done 
in the past. 
1 2 3 4 
4 
I feared that I might lose my job 
if someone found out about my 
illness. 
1 2 3 4 
5 
I felt compelled to change my 
residence because of my illness. 
1 2 3 4 
6 
I avoided getting treatment 
because someone might find out 
about my illness. 
1 2 3 4 
7 
I feared that people would hurt 
my family if they learned about 
my illness. 
1 2 3 4 
8 
I thought other people were 
uncomfortable being with me. 
1 2 3 4 
9 
I felt people avoid me because of 
my illness. 
1 2 3 4 
10 
I feared I would lose my friends 
if they learned about my illness. 
1 2 3 4 
11 
I feared my family would reject 
me if they learned about my 
illness 
1 2 3 4 
12 
I felt I wouldn’t get as good 
health care if people knew about 
my illness. 
1 2 3 4 
13 
People who know I am HIV 
positive treat me with kid gloves. 
1 2 3 4 
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APPENDIX 2: MEDICAL RECORD ABSTRACTION FORM  
 
MEDICAL RECORDS DATA: 
Date of baseline interview:      
Date of T1 interview (7 months after baseline interview):     
 
APPOINTMENTS 
 Date of Appointment Appointment Type State of Appointment 
1    
2    
3    
4    
5    
6    
7    
8    
9    
10    
11    
12    
13    
14    
15    
16    
17    
18    
19    
20    
21    
22    
23    
114 
 
24    
25    
26    
27    
28    
29    
30    
31    
32    
33    
34    
35    
36    
37    
38    
39    
40    
41    
42    
43    
 
115 
 
MR1. Number of appointments scheduled for medical doctor:      
MR2. Number of “no-shows” to medical doctor appointments:      
MR3. Number of appointments scheduled for lab tests:      
MR4. Number of “no-shows” to medical lab test appointments:     
MR5. Total number of scheduled appointments (MR1 + MR3):     
MR6. Total number of “no-showed” appointments (MR2 + MR4):      
 
LAB RESULTS 
 
MR7. CD4 cell count baseline:      
MR7a. Date of CD4 cell count at baseline: ______________ 
 
MR8. CD4 cell count at T1:      
MR8a. Date of CD4 cell count at T1: ______________ 
 
MR9. Viral load baseline:       
MR9a. Date of Viral load at baseline:       
 
MR10. Viral load at T1:       
MR10a. Date of Viral load at T1:       
 
MR 11. Did CD4 count drop below 200 during 7 month follow-up? 
0 no 
1 yes  
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EMERGENCY ROOM SERVICES 
 
 
Date of ER Visit Reason for ER Visit 
State of ER Visit 
Code 0 = Discharged 
 from ER 
Code 1 = Admitted to 
Hospital 
HIV Related? 
Code 0 = Not HIV 
Related 
Code 1 = HIV Related 
1     
2     
3     
4     
5     
6     
7     
8     
9     
10     
11     
12     
13     
14     
15     
16     
17     
18     
19     
20     
21     
22     
23     
24     
25     
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MR12. Did participant use the ER during the 7 month follow-up period? 
0 no 
1 yes  
 
MR12a. If yes, how many times were ER services used during the 7 month follow-up period?  
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HOSPITALIZATION 
 
Date of Hospitalization Reason for Hospitalization 
Medical 
Service 
Number of Days 
Hospitalized 
1     
2     
3     
4     
5     
6     
7     
8     
9     
10     
11     
12     
13     
14     
15     
16     
17     
18     
19     
20     
21     
22     
23     
24     
25     
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MR13. Was the participant hospitalized during the 7 month follow-up period? 
0 no 
1 yes  
 
MR13a. If yes, How many days was the participant hospitalized during the 7 month follow-up 
period?    
 
 
INSURANCE 
MR14. Type of health insurance/how services are paid. 
A. Ryan White 
B. SFAN 
C. Private Insurance 
D. Medicaid 
E. Medicare 
F. No coverage 
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Mental Health Visits 
 Date of Appointment Appointment Type State of Appointment 
1    
2    
3    
4    
5    
6    
7    
8    
9    
10    
11    
12    
13    
14    
15    
16    
17    
18    
19    
20    
21    
22    
23    
24    
25    
26    
27    
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28    
29    
30    
31    
32    
33    
34    
35    
36    
37    
38    
 
MR15. Did the participant use mental health services during retrospective? 
2 no 
1 yes  
MR15a. Number of appointments scheduled for mental health services:      
MR16. Number of “no-shows” to mental health appointments:      
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